The effects of homologous plasma HDL and VHDL fractions on established atherosclerotic lesions were studied in cholesterol-fed rabbits. Atherosclerosis was induced by feeding the animals a 0.5% cholesterol-rich diet for 60 d (group 1). Another group of animals were maintained on the same diet for 90 d (group 2). A third group was also fed the same diet for 90 d but received 50 mg HDL-VHDL protein per wk (isolated from normolipemic rabbit plasma) during the last 30 d (group 3). Aortic atherosclerotic involvement at the completion of the study was 34 +/- 4% in group 1, 38.8 +/- 5% in group 2, and 17.8 +/- 4% in group 3 (P less than 0.005). Aortic lipid deposition was also significantly reduced in group 3 compared with group 1 (studied at only 60 d) and group 2. This is the first in vivo, prospective evidence of the antiatherogenic effect of HDL-VHDL against preexisting atherosclerosis. Our results showed that HDL plasma fractions were able to induce regression of established aortic fatty streaks and lipid deposits. Our results suggest that it may be possible not only to inhibit progression but even to reduce established atherosclerotic lesions by HDL administration.
J J Badimon, L Badimon, V Fuster
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1974 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 3 | 2 | 9 | 12 | 15 | 13 | 21 | 23 | 21 | 18 | 45 | 15 | 19 | 30 | 30 | 26 | 29 | 21 | 21 | 11 | 20 | 17 | 20 | 18 | 18 | 20 | 13 | 18 | 15 | 21 | 19 | 15 | 9 | 7 | 2 | 1 | 618 |
Title and authors | Publication | Year |
---|---|---|
HDL-replacement therapy: From traditional to emerging clinical applications
Sirtori CR, Cincotto G, Castiglione S, Pavanello C |
Atherosclerosis Plus | 2025 |
Effect of moderate-intensity statin on carotid intraplaque neovascularization of coronary artery disease: a retrospective cohort study
Han Y, Ren L, Fei X, Wang J, Chen T, Guo J, Wang Q |
Quantitative imaging in medicine and surgery | 2024 |
Neuroprotective aftermath of Monodora myristica and Glycyrrhiza glabra against cassava diet containing vacuum gas oil induced brain injury in Wistar rats
Okpoghono J, Ukperegbulem JK, Onyesom I |
Toxicology Reports | 2024 |
Nanoparticle-based itaconate treatment recapitulates low-cholesterol/low-fat diet-induced atherosclerotic plaque resolution
Hong NE, Chaplin A, Di L, Ravodina A, Bevan GH, Gao H, Asase C, Gangwar RS, Cameron MJ, Mignery M, Cherepanova O, Finn AV, Nayak L, Pieper AA, Maiseyeu A |
Cell reports | 2024 |
HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS.
Cordero A, Muñoz-García N, Padró T, Vilahur G, Bertomeu-González V, Escribano D, Flores E, Zuazola P, Badimon L |
International journal of molecular sciences | 2023 |
Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk
Murakami K, Harada A, Toh R, Kubo T, Miwa K, Kim J, Kiriyama M, Iino T, Nishikawa Y, Uno SN, Akatsuchi K, Nagao M, Ishida T, Hirata KI |
Scientific Reports | 2023 |
Addressing dyslipidemic risk beyond LDL cholesterol
Alan Tall, David Thomas, Ainara Cabodevilla, Ira Goldberg |
Journal of Clinical Investigation | 2022 |
Atherosclerosis: Methods and Protocols
D Ramji |
2022 | |
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Kalayci A, Gibson CM, Ridker PM, Wright SD, Kingwell BA, Korjian S, Chi G, Lee JJ, Tricoci P, Kazmi SH, Fitzgerald C, Shaunik A, Berman G, Duffy D, Libby P |
Current Atherosclerosis Reports | 2022 |
Fat-1 expression alleviates atherosclerosis in transgenic rabbits.
Zhang C, Wang X, Sun S, Fu Y, Wu Y, Zhao S, Fan X, Liu E |
Journal of Cellular and Molecular Medicine | 2022 |
Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection.
Kadji Fassi JB, Boukeng Jatsa H, Membe Femoe U, Greigert V, Brunet J, Cannet C, Kenfack CM, Gipwe Feussom N, Tienga Nkondo E, Abou-Bacar A, Pfaff AW, Kamgang R, Kamtchouing P, Tchuem Tchuenté LA |
PLoS neglected tropical diseases | 2022 |
OXIDATIVE MODIFICATION OF HDL BY LIPID ALDEHYDES IMPACTS HDL FUNCTION
Fadaei R, Davies SS |
Archives of Biochemistry and Biophysics | 2022 |
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein A, Nordestgaard BG, Remaley AT, Catapano AL |
European Heart Journal | 2022 |
Consumption of Barley Bread Rich in Beta-Glucan During an Overfeeding Improves the Serum Lipid Profile and Balances the Intestinal Microbiota in Wistar Rats.
Kaoutar B, Kawthar B, Omar K |
Indian Journal of Microbiology | 2022 |
Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages
Kluck GE, Qian AS, Sakarya EH, Quach H, Deng YD, Trigatti BL |
Arteriosclerosis, thrombosis, and vascular biology | 2022 |
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
L Schoch, L Badimon, G Vilahur |
Biomedicines | 2021 |
Is a High HDL-Cholesterol Level Always Beneficial?
B Franczyk, J Rysz, J Ławiński, M Rysz-Górzyńska, A Gluba-Brzózka |
Biomedicines | 2021 |
HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
BA Bartolo, SP Cartland, S Genner, PM Cholan, M Vellozzi, KA Rye, MM Kavurma, FC Sasso |
Journal of Diabetes Research | 2021 |
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
KT Lappegård, CA Kjellmo, A Hovland |
Biomedicines | 2021 |
HDL cholesterol: A potential mediator of the association between urinary cadmium concentration and cardiovascular disease risk
C Xu, Z Weng, L Zhang, J Xu, M Dahal, TB Basnet, A Gu |
Ecotoxicology and Environmental Safety | 2021 |
The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease
Y Jia, W Wen, Y Yang, M Huang, Y Ning, X Jiao, S Liu, Y Qin, M Zhang |
Clinical Biochemistry | 2021 |
Incidence and risk factors predicting deep venous thrombosis of lower extremity following spinal fractures
J Ma, P Du, J Qin, Y Zhou, N Liang, J Hu, Y Zhang, Y Zhu |
Scientific Reports | 2021 |
(r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?
KB Uribe, A Benito-Vicente, C Martin, F Blanco-Vaca, N Rotllan |
Biomaterials Science | 2021 |
Anti-Atherogenic Effect of 10% Supplementation of Anchovy (Engraulis encrasicolus) Waste Protein Hydrolysates in ApoE-Deficient Mice
JM Abbate, F Macrì, F Arfuso, C Iaria, F Capparucci, C Anfuso, A Ieni, L Cicero, G Briguglio, G Lanteri |
Nutrients | 2021 |
Comparative effects of ethanol leaf and stem bark extracts of Irvingia gabonensis (BUSH MANGO) on sodium arsenite-induced lipid profile perturbtions in wistar rats
EG Ewere, NP Okolie, ED Avan, PE Umoh |
Clinical Phytoscience | 2021 |
Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics
DP Schrijver, A Dreu, SR Hofstraat, E Kluza, R Zwolsman, J Deckers, T Anbergen, K Bruin, MM Trines, EG Nugraha, F Ummels, RJ Röring, TJ Beldman, AJ Teunissen, ZA Fayad, R Meel, WJ Mulder |
2021 | |
Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats
C KAHRAMAN, H YAMAN |
2021 | |
Macrophages in Atherosclerosis Regression
TJ Barrett |
Arteriosclerosis, thrombosis, and vascular biology | 2020 |
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
EE Morin, Y Guo, H He, W Yuan, WN Souery, MV Fawaz, YE Chen, A Schwendeman |
Frontiers in pharmacology | 2020 |
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris |
2020 | |
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris |
2020 | |
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris |
2020 | |
Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins
U Hoeger, JR Harris |
2020 | |
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
J Borén, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, MJ Daemen, LL Demer, RA Hegele, SJ Nicholls, BG Nordestgaard, GF Watts, E Bruckert, S Fazio, BA Ference, I Graham, JD Horton, U Landmesser, U Laufs, L Masana, G Pasterkamp, FJ Raal, KK Ray, H Schunkert, MR Taskinen, B van de Sluis, O Wiklund, L Tokgozoglu, AL Catapano, HN Ginsberg |
European Heart Journal | 2020 |
Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis
M Zamanian-Daryoush, V Gogonea, AJ DiDonato, JA Buffa, I Choucair, BS Levison, RA Hughes, AD Ellington, Y Huang, XS Li, JA DiDonato, SL Hazen |
The Journal of biological chemistry | 2020 |
Immunization with the Gly 1127 -Cys 1140 amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies
O Bornachea, A Benitez-Amaro, A Vea, L Nasarre, D de Gonzalo-Calvo, JC Escola-Gil, L Cedo, A Iborra, L Martínez-Martínez, C Juarez, JA Camara, C Espinet, M Borrell-Pages, L Badimon, J Castell, V Llorente-Cortés |
Theranostics | 2020 |
Hyperlipidaemia and cardioprotection: Animal models for translational studies
I Andreadou, R Schulz, L Badimon, A Adameová, P Kleinbongard, S Lecour, PE Nikolaou, I FalcãoPires, G Vilahur, N Woudberg, G Heusch, P Ferdinandy |
British Journal of Pharmacology | 2020 |
Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
S Jebari-Benslaiman, KB Uribe, A Benito-Vicente, U Galicia-Garcia, A Larrea-Sebal, I Alloza, K Vandenbroeck, H Ostolaza, C Martín |
Biomedicines | 2020 |
Association of high-density lipoprotein levels with baseline coronary plaque volumes by coronary CTA in the EVAPORATE trial
S Lakshmanan, C Shekar, A Kinninger, S Dahal, A Onuegbu, AN Cai, S Hamal, D Birudaraju, L Cherukuri, F Flores, C Dailing, SK Roy, DL Bhatt, JR Nelson, MJ Budoff |
Atherosclerosis | 2020 |
Textbook of Sports and Exercise Cardiology
A Pressler, J Niebauer |
2020 | |
Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development
M Niimi, Y Chen, H Yan, Y Wang, T Koike, J Fan |
Applied Sciences | 2020 |
ASSOCIATION OF IRISIN WITH THE OXIDANT-ANTI OXIDANT PARAMETERS IN TYPE 2 DIABETIC PATIENTS ACCORDING TO AGE IN THI-QAR PROVINCE/ IRAQ
SH Al-Badry, KG Al-Fartoosi |
2020 | |
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
D Wang, Y Yang, Y Lei, NT Tzvetkov, X Liu, AW Yeung, S Xu, AG Atanasov, Q Ma |
Pharmacological reviews | 2019 |
Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice
K Méndez-Lara, N Farré, D Santos, A Rivas-Urbina, J Metso, J Sánchez-Quesada, V Llorente-Cortes, T Errico, E Lerma, M Jauhiainen, J Martín-Campos, N Alonso, J Escolà-Gil, F Blanco-Vaca, J Julve |
International journal of molecular sciences | 2019 |
HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension
K Jonas, G Kopeć |
International journal of molecular sciences | 2019 |
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure
CR Sirtori, M Ruscica, L Calabresi, G Chiesa, R Giovannoni, JJ Badimon |
Annals of Medicine | 2019 |
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis
S Shea, JH Stein, NW Jorgensen, RL McClelland, L Tascau, S Shrager, JW Heinecke, L Yvan-Charvet, AR Tall |
Arteriosclerosis, thrombosis, and vascular biology | 2019 |
The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
H Daida, T Dohi, Y Fukushima, H Ohmura, K Miyauchi |
Journal of Atherosclerosis and Thrombosis | 2019 |
HDL and ASCVD Risk Stratification – A Debate
P Barter, J Genest |
Atherosclerosis | 2019 |
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques
P Fotakis, V Kothari, DG Thomas, M Westerterp, MM Molusky, E Altin, S Abramowicz, N Wang, Y He, JW Heinecke, KE Bornfeldt, AR Tall |
Arteriosclerosis, thrombosis, and vascular biology | 2019 |
Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects
A Hernández-Mijares, JF Ascaso, M Blasco, Á Brea, Á Díaz, T Mantilla, J Pedro-Botet, X Pintó, J Millán |
Clínica e Investigación en Arteriosclerosis (English Edition) | 2019 |
Fundamentals of Vascular Biology
M Geiger |
2019 | |
Mathematical Modelling and Simulation of Atherosclerosis Formation and Progress: A Review
NA Avgerinos, P Neofytou |
Annals of Biomedical Engineering | 2019 |
A Compendium of the Biological Effects of Apolipoprotein A-I Milano
C Parolini |
The Journal of pharmacology and experimental therapeutics | 2019 |
A Photo-Activatable Peptide Mimicking Functions of Apolipoprotein A-I
H Kawahara, N Miyashita, K Tachibana, Y Tsuda, K Morimoto, K Tsuji, A Shigenaga, A Otaka, T Ishida, K Okuhira |
Biological & Pharmaceutical Bulletin | 2019 |
Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression
K Rahman, EA Fisher |
Frontiers in Cardiovascular Medicine | 2018 |
Pharmacological Intervention to Modulate HDL: What Do We Target?
NJ Woudberg, S Pedretti, S Lecour, R Schulz, N Vuilleumier, RW James, MA Frias |
Frontiers in pharmacology | 2018 |
Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease
A Haghikia, U Landmesser |
JACC: Basic to Translational Science | 2018 |
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial
SJ Nicholls, J Andrews, JJ Kastelein, B Merkely, SE Nissen, KK Ray, GG Schwartz, SG Worthley, C Keyserling, JL Dasseux, L Griffith, SW Kim, A Janssan, GD Giovanni, AD Pisaniello, DJ Scherer, PJ Psaltis, J Butters |
JAMA Cardiology | 2018 |
Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation
AR Tall |
Atherosclerosis | 2018 |
移植肾动脉狭窄的临床危险因素和保护因素
|
2018 | |
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial
SJ Nicholls, R Puri, CM Ballantyne, JW Jukema, JJ Kastelein, W Koenig, RS Wright, D Kallend, P Wijngaard, M Borgman, K Wolski, SE Nissen |
JAMA Cardiology | 2018 |
CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both
SJ Nicholls |
Clinical Pharmacology & Therapeutics | 2018 |
High-Density Lipoprotein Infusions
K Takata, BA Bartolo, SJ Nicholls |
Cardiology Clinics | 2018 |
Antioxidant capacity of omega-3-fatty acids and vitamin E against imidacloprid-induced hepatotoxicity in Japanese quails
H Emam, E Ahmed, M Abdel-Daim |
Environmental Science and Pollution Research | 2018 |
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
I Karalis, JW Jukema |
Current Cardiology Reports | 2018 |
Cholesterol - Good, Bad and the Heart
ML Nagpal |
2018 | |
Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage
VA Kudinov, TS Zakharova, TI Torkhovskaya, OM Ipatova, АI Archakov |
Biomeditsinskaya Khimiya | 2018 |
Lipoprotein in cholesterol transport: Highlights and recent insights into its structural basis and functional mechanism
SY Chen, N Li, TL Jin, L Gou, DX Hao, ZQ Tian, SL Zhang, L Zhang |
Chinese Physics B | 2018 |
Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use
VA Kudinov, TS Zakharova, TI Torkhovskaya, OM Ipatova, AI Archakov |
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | 2018 |
High-Density Lipoprotein–Targeted Therapies—Not Dead Yet
A Garcia-Ropero, CG Santos-Gallego, JJ Badimon |
JAMA Cardiology | 2018 |
Translating Evidence of HDL and Plaque Regression
BA Bartolo, PJ Psaltis, CA Bursill, SJ Nicholls |
Arteriosclerosis, thrombosis, and vascular biology | 2018 |
Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos
A Hernández-Mijares, JF Ascaso, M Blasco, Á Brea, Á Díaz, T Mantilla, J Pedro-Botet, X Pintó, J Millán |
Clínica e Investigación en Arteriosclerosis | 2018 |
Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: A novel index for the prediction of HDL functionality
CM Shih, FY Lin, JS Yeh, YW Lin, SH Loh, NW Tsao, H Nakagami, R Morishita, T Sawamura, CY Li, CY Lin, CY Huang |
Translational research : the journal of laboratory and clinical medicine | 2018 |
Endovascular Interventions
JM Wiley, C Sanina, P Faries, ID Conde, GD Dangas, P Krishnan |
2018 | |
[A high level of high-density lipoprotein cholesterol is a protective factor against transplant renal artery stenosis]
Yan-Na Liu, Li-Xin Yu, Wen-Feng Deng, Kai-Qun Li, Ru-Min Liu, Gui-Rong Ye, Fang-Xiang Fu, Jiang-Tao Li, Yun Miao |
Nan fang yi ke da xue xue bao = Journal of Southern Medical University | 2018 |
Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism: Inflammation and HDL-C metabolism
F Iqbal, WS Baker, MI Khan, S Thukuntla, KH McKinney, N Abate, D Tuvdendorj |
British Journal of Pharmacology | 2017 |
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
HH Wang, G Garruti, M Liu, P Portincasa, DQ Wang |
ANN HEPATOL | 2017 |
HDL cholesterol: reappraisal of its clinical relevance
W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, KG Parhofer, A Eckardstein, U Landmesser, U Laufs |
Clinical Research in Cardiology | 2017 |
Effects of Dietary Flavonoids on Reverse Cholesterol Transport, HDL Metabolism, and HDL Function
CL Millar, Q Duclos, CN Blesso |
Advances in nutrition (Bethesda, Md.) | 2017 |
The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review
A Pizzini, L Lunger, E Demetz, R Hilbe, G Weiss, C Ebenbichler, I Tancevski |
Nutrients | 2017 |
Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
J Martin-Ventura, R Rodrigues-Diez, D Martinez-Lopez, M Salaices, L Blanco-Colio, A Briones |
International journal of molecular sciences | 2017 |
Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance
N Paulin, Y Döring, S Kooijman, X Blanchet, JR Viola, R Jong, M Mandl, J Hendrikse, M Schiener, P Hundelshausen, A Vogt, C Weber, K Bdeir, SM Hofmann, PC Rensen, M Drechsler, O Soehnlein |
EBioMedicine | 2017 |
Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression
AD Chalmers, CA Bursill, MR Myerscough, AV Panfilov |
PloS one | 2017 |
High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
E Androulakis, E Zacharia, N Papageorgiou, E Lioudaki, D Bertsias, M Charakida, G Siasos, D Tousoulis |
Current cardiology reviews | 2017 |
Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo
F Maafi, B Li, C Gebhard, MR Brodeur, W Nachar, L Villeneuve, F Lesage, D Rhainds, E Rhéaume, JC Tardif |
Atherosclerosis | 2017 |
HDL cholesterol concentration or HDL function: which matters?
PJ Barter, KA Rye |
European Heart Journal | 2017 |
Biofunctional polymer-lipid hybrid high density lipoprotein-mimicking nanoparticles loading anti-miR155 for combined antiatherogenic effects on macrophages
J Lu, Y Zhao, X Zhou, JH He, Y Yang, C Jiang, Z Qi, W Zhang, J Liu |
Biomacromolecules | 2017 |
Nanoplumbers: biomaterials to fight cardiovascular diseases
F Dormont, M Varna, P Couvreur |
Materials Today | 2017 |
Protective effects of Eruca sativa (rocket) on abamectin insecticide toxicity in male albino rats
NM Meligi, HF Hassan |
Environmental Science and Pollution Research | 2017 |
Type V hypertriglyceridemia in children, a therapeutic challenge in pediatrics: A case report and a review of the literature
CO Mărginean, LE Meliţ, M Dobreanu, MO Mărginean |
Medicine | 2017 |
Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe Obesity
A Iqbal, A Dahl, A Lteif, S Kumar |
Children | 2017 |
Association between high-density lipoprotein cholesterol level and pulmonary function in healthy Korean adolescents: the JS high school study
JH Park, S Mun, DP Choi, JY Lee, HC Kim |
BMC Pulmonary Medicine | 2017 |
Effect of Ginkgo biloba Extract (EGb 761) on Serum Cholesterol Levels in Wild-type C57Bl/6 Mice
JS Hong, JW Kim, BI Yoon, KJ Rhee, CS Rha, BD Jung |
Biomedical Science Letters | 2017 |
High-Density Lipoprotein Nanobiologics for Precision Medicine
WJ Mulder, MM van Leent, M Lameijer, EA Fisher, ZA Fayad, C Pérez-Medina |
Accounts of Chemical Research | 2017 |
HDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?
EP van der Vorst, K Theodorou, EA Biessen, MM Donners |
Expert Review of Cardiovascular Therapy | 2017 |
Petroleum ether extract of Njavara rice ( Oryza sativa ) bran upregulates the JAK2–STAT3-mediated anti-inflammatory profile in macrophages and aortic endothelial cells promoting regression of atherosclerosis
PK Chithra, A Jayalekshmy, A Helen |
Biochemistry and Cell Biology | 2017 |
Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study
J Andrews, A Janssan, T Nguyen, AD Pisaniello, DJ Scherer, JJ Kastelein, B Merkely, SE Nissen, K Ray, GG Schwartz, SG Worthley, C Keyserling, JL Dasseux, J Butters, J Girardi, R Miller, SJ Nicholls |
Cardiovascular diagnosis and therapy | 2017 |
Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
BA di Bartolo, N Schwarz, J Andrews, SJ Nicholls |
Archives of Medical Science : AMS | 2017 |
miRNAs and High-Density Lipoprotein metabolism
Á Baldán, TQ de Vallim |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2016 |
Micro-RNAs and High-Density Lipoprotein MetabolismHighlights
A Canfrán-Duque, CS Lin, L Goedeke, Y Suárez, C Fernández-Hernando |
Arteriosclerosis, thrombosis, and vascular biology | 2016 |
Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate Lipopolysaccharide-Induced Inflammation and Acute Lung Injury
AV Bocharov, T Wu, IN Baranova, AA Birukova, D Sviridov, TG Vishnyakova, AT Remaley, TL Eggerman, AP Patterson, KG Birukov |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
HDL—A molecule with a multi-faceted role in coronary artery disease
S Arora, SK Patra, R Saini |
Clinica Chimica Acta | 2016 |
Klinische Bedeutung des HDL-Cholesterins
W März, ME Kleber, H Scharnagl, T Speer, S Zewinger, A Ritsch, KG Parhofer, A Eckardstein, U Landmesser, U Laufs |
Herz | 2016 |
New Era of Lipid-Lowering Drugs
PJ Barter, KA Rye |
Pharmacological reviews | 2016 |
Plaque stabilizing effects of apolipoprotein A-IV
FR Geronimo, PJ Barter, KA Rye, AK Heather, KD Shearston, KJ Rodgers |
Atherosclerosis | 2016 |
Animal models of myocardial infarction: Mainstay in clinical translation
M Kumar, ER Kasala, LN Bodduluru, V Dahiya, D Sharma, V Kumar, M Lahkar |
Regulatory Toxicology and Pharmacology | 2016 |
Long-term activation of the innate immune system in atherosclerosis
A Christ, S Bekkering, E Latz, NP Riksen |
Seminars in Immunology | 2016 |
Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio
S Kaul, H Xu, M Zabalawi, E Maruko, BE Fulp, T Bluemn, KL BrzozaLewis, M Gerelus, R Weerasekera, R Kallinger, R James, YS Zhang, MJ Thomas, MG SorciThomas |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2016 |
The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications
JE Feig, JL Feig, GD Dangas |
Coronary Artery Disease | 2016 |
The unresolved mystery of high-density lipoprotein: time for a paradigm shift?
B Enkhmaa, E Anuurad, L Berglund |
Translational Research | 2016 |
ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia
J Cubedo, T Padró, R Alonso, P Mata, L Badimon |
Journal of lipid research | 2016 |
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction
CM Gibson, S Korjian, P Tricoci, Y Daaboul, JH Alexander, PG Steg, AM Lincoff, JJ Kastelein, R Mehran, D D'Andrea, B Merkely, M Zarebinski, TO Ophius, RA Harrington |
American Heart Journal | 2016 |
New Therapeutic Approaches to the Treatment of Dyslipidemia
DJ Rader |
Cell Metabolism | 2016 |
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
C Pérez-Medina, T Binderup, ME Lobatto, J Tang, C Calcagno, L Giesen, CH Wessel, J Witjes, S Ishino, S Baxter, Y Zhao, S Ramachandran, M Eldib, BL Sánchez-Gaytán, PM Robson, J Bini, JF Granada, KM Fish, ES Stroes, R Duivenvoorden, S Tsimikas, JS Lewis, T Reiner, V Fuster, A Kjær, EA Fisher, ZA Fayad, WJ Mulder |
JACC: Cardiovascular Imaging | 2016 |
HDL mimetic CER-001 targets atherosclerotic plaques in patients
KH Zheng, FM van der Valk, LP Smits, M Sandberg, JL Dasseux, R Baron, R Barbaras, C Keyserling, BF Coolen, AJ Nederveen, HJ Verberne, TE Nell, DJ Vugts, R Duivenvoorden, ZA Fayad, WJ Mulder, GA van Dongen, ES Stroes |
Atherosclerosis | 2016 |
Using Mendelian Randomization Studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine
W Zhao, JJ Lee, A Rasheed, D Saleheen |
Current Genetic Medicine Reports | 2016 |
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East
NA Sayed, KA Waili, F Alawadi, S Al-Ghamdi, WA Mahmeed, F Al-Nouri, MA Rukhaimi, K Al-Rasadi, Z Awan, M Farghaly, M Hassanein, H Sabbour, M Zubaid, P Barter |
International Journal of Cardiology | 2016 |
Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of AtherosclerosisHighlights
BK Wacker, N Dronadula, J Zhang, DA Dichek |
Arteriosclerosis, thrombosis, and vascular biology | 2016 |
Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond
BA di Bartolo, DJ Scherer, SJ Nicholls |
Archives of Medical Science : AMS | 2016 |
HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation
C Tardy, M Goffinet, N Boubekeur, G Cholez, R Ackermann, G Sy, C Keyserling, N Lalwani, JF Paolini, JL Dasseux, R Barbaras, R Baron, A Cignarella |
PloS one | 2015 |
A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion
RE Temel, JM Brown |
Trends in Pharmacological Sciences | 2015 |
Cholesterol, inflammation and innate immunity
AR Tall, L Yvan-Charvet |
Nature Reviews Immunology | 2015 |
Novel methodologies for biomarker discovery in atherosclerosis
IE Hoefer, S Steffens, M Ala-Korpela, M Back, L Badimon, ML Bochaton-Piallat, CM Boulanger, G Caligiuri, S Dimmeler, J Egido, PC Evans, T Guzik, BR Kwak, U Landmesser, M Mayr, C Monaco, G Pasterkamp, J Tunon, C Weber |
European Heart Journal | 2015 |
Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine
J Fan, S Kitajima, T Watanabe, J Xu, J Zhang, E Liu, YE Chen |
Pharmacology & Therapeutics | 2015 |
HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
KY Chyu, PK Shah |
Frontiers in pharmacology | 2015 |
Targeting High-Density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?
PJ Barter, KA Rye |
Clinical Therapeutics | 2015 |
Egg Phospholipids and Cardiovascular Health
C Blesso |
Nutrients | 2015 |
Innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C/ LDL-C-lowering versus HDL-C-raising A systematic review and meta-analysis of relevant preclinical studies and clinical trials
S Kühnast, M Fiocco, JW van der Hoorn, HM Princen, JW Jukema |
European Journal of Pharmacology | 2015 |
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
D Saleheen, R Scott, S Javad, W Zhao, A Rodrigues, A Picataggi, D Lukmanova, ML Mucksavage, R Luben, J Billheimer, JJ Kastelein, SM Boekholdt, KT Khaw, N Wareham, DJ Rader |
The Lancet Diabetes & Endocrinology | 2015 |
The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory: The Dual Nature of HDL
R Namiri-Kalantari, F Gao, A Chattopadhyay, AA Wheeler, KD Navab, R Farias-Eisner, ST Reddy |
BioFactors | 2015 |
A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients
J Cubedo, T Padro, M Garcia-Arguinzonis, G Vilahur, I Minambres, JM Pou, J Ybarra, L Badimon |
Journal of lipid research | 2015 |
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties
A Schwendeman, DO Sviridov, W Yuan, Y Guo, EE Morin, Y Yuan, J Stonik, L Freeman, A Ossoli, S Thacker, S Killion, M Pryor, YE Chen, S Turner, AT Remaley |
Journal of lipid research | 2015 |
Non-clinical development of CER-001
R Barbaras |
Frontiers in pharmacology | 2015 |
Novel Anti-Inflammatory Therapies for the Treatment of Atherosclerosis
R Khan, V Spagnoli, JC Tardif, PL L’Allier |
Atherosclerosis | 2015 |
Glycated apolipoprotein B—A surrogate marker of subclinical atherosclerosis
K Dev, SB Sharma, S Garg, A Aggarwal, SV Madhu |
Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2015 |
HDL: quality or quantity?
CG Santos-Gallego |
Atherosclerosis | 2015 |
The role of a murine transplantation model of atherosclerosis regression in drug discovery
Jonathan E Feig, John S Quick, Edward A Fisher |
Current opinion in investigational drugs (London, England : 2000) | 2015 |
Site-specific Nitration of Apolipoprotein A-I at Tyrosine 166 Is Both Abundant within Human Atherosclerotic Plaque and Dysfunctional
JA DiDonato, K Aulak, Y Huang, M Wagner, G Gerstenecker, C Topbas, V Gogonea, AJ DiDonato, WH Tang, RA Mehl, PL Fox, EF Plow, JD Smith, EA Fisher, SL Hazen |
The Journal of biological chemistry | 2014 |
An abundant dysfunctional apolipoprotein A1 in human atheroma
Y Huang, JA DiDonato, BS Levison, D Schmitt, L Li, Y Wu, J Buffa, T Kim, GS Gerstenecker, X Gu, CS Kadiyala, Z Wang, MK Culley, JE Hazen, AJ DiDonato, X Fu, SZ Berisha, D Peng, TT Nguyen, S Liang, CC Chuang, L Cho, EF Plow, PL Fox, V Gogonea, WH Tang, JS Parks, EA Fisher, JD Smith, SL Hazen |
Nature Medicine | 2014 |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
High Density Lipoproteins
A von Eckardstein, D Kardassis |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics
J Camps |
2014 | |
Molecules That Mimic Apolipoprotein A-I: Potential Agents for Treating Atherosclerosis
LJ Leman, BE Maryanoff, MR Ghadiri |
Journal of Medicinal Chemistry | 2014 |
Beginning to Understand High-Density Lipoproteins
CG Santos-Gallego, JJ Badimon, RS Rosenson |
Endocrinology and metabolism clinics of North America | 2014 |
High-Density Lipoprotein and Atherosclerosis Regression: Evidence From Preclinical and Clinical Studies
JE Feig, B Hewing, JD Smith, SL Hazen, EA Fisher |
Circulation research | 2014 |
Regression of Atherosclerosis: Insights from Animal and Clinical Studies
JE Feig |
Annals of Global Health | 2014 |
Immunonutrition: Interactions of Diet, Genetics, and Inflammation
Z Li, D Heber |
Immunonutrition: Interactions of Diet, Genetics, and Inflammation | 2014 |
Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction
J Cubedo, T Padró, L Badimon |
Translational Research | 2014 |
HDL Cholesterol: All Hope Is Not Lost After the Torcetrapib Setback—Emerging Therapeutic Strategies on the Horizon
N Verma, VM Figueredo |
American Journal of Therapeutics | 2014 |
Trying to harness the potential of HDL: wishful thinking or sound strategy?
AM Fogelman |
European Heart Journal | 2014 |
HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: In vivo and in vitro studies: HDL3 Stimulates PON1 Antiatherogenic Properties
M Rosenblat, N Volkova, M Aviram |
BioFactors | 2014 |
Intake of cooked tomato sauce preserves coronary endothelial function and improves apolipoprotein A-I and apolipoprotein J protein profile in high-density lipoproteins
G Vilahur, J Cubedo, T Padró, L Casaní, G Mendieta, A González, L Badimon |
Translational Research | 2014 |
Modulating reconstituted high density lipoprotein functionality to target the Pseudomonas aeruginosa quorum sensing system
SP Deakin, V Ducret, S Bioletto, K Perron, RW James |
Life Sciences | 2014 |
Revising the high-density lipoprotein targeting strategies – Insights from human and preclinical studies
D Nesan, DS Ng |
Critical Reviews in Clinical Laboratory Sciences | 2014 |
HDL and cardiovascular disease
DJ Rader, GK Hovingh |
The Lancet | 2014 |
Examining controversies and new frontiers in lipid management
SJ Nicholls |
Clinical Lipidology | 2014 |
Cholesterol removal from plaques and elimination from the body: change in paradigm to reduce risk for heart disease
S Ghosh, J Bie, J Wang, Q Yuan, SS Ghosh |
Clinical Lipidology | 2014 |
High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need
Giovanni Cimmino, Giovanni Ciccarelli, Alberto Morello, Michele Ciccarelli, Paolo Golino |
Translational medicine @ UniSa | 2014 |
Atherosclerotic Plaque Imaging for Evaluation of HDL Targeting Therapy
Y Kataoka, SJ Nicholls |
Journal of the Japanese Coronary Association | 2014 |
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.
Tenenbaum A, Klempfner R, Fisman EZ |
Cardiovascular Diabetology | 2014 |
Niacin, an old drug with a new twist
WL Song, GA FitzGerald |
Journal of lipid research | 2013 |
High density lipoprotein structure, function, and metabolism: a new Thematic Series
KA Rye |
Journal of lipid research | 2013 |
Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity
AJ Murphy, S Funt, D Gorman, AR Tall, N Wang |
Circulation research | 2013 |
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice
C Tardy, M Goffinet, N Boubekeur, R Ackermann, G Sy, A Bluteau, G Cholez, C Keyserling, N Lalwani, JF Paolini, JL Dasseux, R Barbaras, R Baron |
Atherosclerosis | 2013 |
High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
PJ Barter |
Endocrinology and Metabolism | 2013 |
Cardioprotective functions of HDLs
KA Rye, PJ Barter |
Journal of lipid research | 2013 |
A perspective for atherosclerosis vaccination: Is there a place for plant-based vaccines?
JA Salazar-González, S Rosales-Mendoza |
Vaccine | 2013 |
Recent progress in the development of apoA-I and apoE mimetic therapies
GM Anantharamaiah, DW Garber |
Clinical Lipidology | 2013 |
Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research
M Triolo, W Annema, RP Dullaart, UJ Tietge |
Biomarkers in Medicine | 2013 |
Animal Models for the Study of Human Disease
HA Lawson |
Animal Models for the Study of Human Disease | 2013 |
Validation of a novel homogeneous assay for of HDL3-C measurement
ME Ashmaig, S Gupta, JP McConnell, GR Warnick |
Clinica Chimica Acta | 2013 |
High-density lipoproteins: A consensus statement from the National Lipid Association
PP Toth, PJ Barter, RS Rosenson, WE Boden, MJ Chapman, M Cuchel, RB D'Agostino, MH Davidson, WS Davidson, JW Heinecke, RH Karas, A Kontush, RM Krauss, M Miller, DJ Rader |
Journal of Clinical Lipidology | 2013 |
Reconstituted HDL for the acute treatment of acute coronary syndrome:
BR Krause, AT Remaley |
Current Opinion in Lipidology | 2013 |
Modelos experimentales de aterosclerosis
CG Santos-Gallego, JJ Badimon, B Ibáñez |
Revista Española de Cardiología Suplementos | 2013 |
Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding
Kempen, O Fedorov, P Filippakopoulos, S Nicklisch, S Knapp, S Picaud |
Lipid insights | 2013 |
Emerging Role of Mast Cells and Macrophages in Cardiovascular and Metabolic Diseases
JM Xu, GP Shi |
Endocrine reviews | 2012 |
Macrophages, dendritic cells, and regression of atherosclerosis
JE Feig, JL Feig |
Frontiers in physiology | 2012 |
Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
C Ibuki, Y Seino, T Otsuka, N Kimata, T Inami, R Munakata, K Mizuno |
Journal of clinical medicine research | 2012 |
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
C Besler, TF Lüscher, U Landmesser |
EMBO Molecular Medicine | 2012 |
High-density lipoprotein function, dysfunction, and reverse cholesterol transport
EA Fisher, JE Feig, B Hewing, SL Hazen, JD Smith |
Arteriosclerosis, thrombosis, and vascular biology | 2012 |
HDL and cardiovascular risk: time to call the plumber?
B Hewing, KJ Moore, EA Fisher |
Circulation research | 2012 |
Evacetrapib
SJ Nicholls |
Current Cardiology Reports | 2012 |
The Rabbit as an Experimental Model
TH Burkholder, G Linton, RF Hoyt, R Young |
The Laboratory Rabbit Guinea Pig Hamster and Other Rodents | 2012 |
ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies
SJ Nicholls, A Gordon, J Johannson, CM Ballantyne, PJ Barter, HB Brewer, JJ Kastelein, NC Wong, MR Borgman, SE Nissen |
Cardiovascular Drugs and Therapy | 2012 |
Targeting HDL-cholesterol to reduce residual cardiovascular risk :
AO Iacob, RP Choudhury |
Current Opinion in Lipidology | 2012 |
High-density lipoprotein subclasses and their relationship to cardiovascular disease
HR Superko, L Pendyala, PT Williams, KM Momary, SB King, BC Garrett |
Journal of Clinical Lipidology | 2012 |
Intracoronary IVUS for Evaluation of Atherosclerosis Progression
K Uno, Y Kataoka, R Puri, SJ Nicholls |
Current Cardiovascular Imaging Reports | 2012 |
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance
F Borthwick, S Warnakula, R Mangat, RR Uwiera, JC Russell, SE Kelly, CY Lee, L Hryshko, JC Mamo, KA Rye, GD Lopaschuk, SD Proctor |
Atherosclerosis | 2012 |
Production of Plasma Proteins for Therapeutic Use: Bertolini/Plasma Proteins
S Chtourou, M Poulle |
Production of Plasma Proteins for Therapeutic Use: Bertolini/Plasma Proteins | 2012 |
Atherosclerosis: Treatment and Prevention
GP Shi, P Libby |
Atherosclerosis: Treatment and Prevention | 2012 |
HDL-C: Does it matter? An update on novel HDL-directed pharmaco-therapeutic strategies
R Gadi, A Amanullah, VM Figueredo |
International Journal of Cardiology | 2012 |
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
PJ Barter, KA Rye |
Journal of lipid research | 2012 |
Age- and gender dependent association between components of metabolic syndrome and subclinical arterial stiffness in a Chinese population
C Weng, H Yuan, X Tang, Z Huang, K Yang, W Chen, P Yang, Z Chen, F Chen |
International journal of medical sciences | 2012 |
A Leukocyte-Mimetic Magnetic Resonance Imaging Contrast Agent Homes Rapidly to Activated Endothelium and Tracks With Atherosclerotic Lesion Macrophage Content
MA McAteer, K Mankia, N Ruparelia, A Jefferson, HB Nugent, LA Stork, KM Channon, JE Schneider, RP Choudhury |
Arteriosclerosis, thrombosis, and vascular biology | 2012 |
Antagonism of miR-33 in Mice Promotes Reverse Cholesterol Transport and Regression of Atherosclerosis
Katey J. Rayner, Frederick J. Sheedy, Christine C. Esau, Farah N. Hussain, Ryan E. Temel, Saj Parathath, Janine M. van Gils, Alistair J. Rayner, Aaron N. Chang, Yajaira Suarez, Carlos Fernandez-Hernando, Edward A. Fisher, Kathryn J. Moore |
Journal of Clinical Investigation | 2011 |
Novel HDL-directed pharmacotherapeutic strategies
EM Degoma, DJ Rader |
Nature reviews. Cardiology | 2011 |
Experimental Models for the Investigation of High-Density Lipoprotein–Mediated Cholesterol Efflux
CG Santos-Gallego, C Giannarelli, JJ Badimón |
Current Atherosclerosis Reports | 2011 |
MicroRNA Modulation of Cholesterol Homeostasis
C Fernández-Hernando, KJ Moore, WC Sessa |
Arteriosclerosis, thrombosis, and vascular biology | 2011 |
A Systems Genetic Analysis of High Density Lipoprotein Metabolism and Network Preservation across Mouse Models
P Langfelder, LW Castellani, Z Zhou, E Paul, R Davis, EE Schadt, AJ Lusis, S Horvath, M Mehrabian |
Biochimica et Biophysica Acta | 2011 |
HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells
JE Feig, JX Rong, R Shamir, M Sanson, Y Vengrenyuk, J Liu, K Rayner, K Moore, M Garabedian, EA Fisher |
Proceedings of the National Academy of Sciences | 2011 |
The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice
I Zanotti, C Maugeais, M Pedrelli, M Gomaraschi, P Salgam, L Calabresi, F Bernini, H Kempen |
British Journal of Pharmacology | 2011 |
Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies
EV Craeyveld, SC Gordts, E Nefyodova, F Jacobs, BD Geest |
Journal of Molecular Medicine | 2011 |
Apo A-I Modulating Therapies
SJ Nicholls |
Current Cardiology Reports | 2011 |
Emerging therapeutic strategies to enhance HDL function
S Redondo, J Martínez-González, C Urraca, T Tejerina |
Lipids in Health and Disease | 2011 |
Effects of niacin on atherosclerosis and vascular function
N Ruparelia, JE Digby, RP Choudhury |
Current Opinion in Cardiology | 2011 |
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
ME Lobatto, V Fuster, ZA Fayad, WJ Mulder |
Nature Reviews Drug Discovery | 2011 |
The beneficial effects of HDL-C on atherosclerosis: rationale and clinical results
CG Santos-Gallego, F Torres, JJ Badimón |
Clinical Lipidology | 2011 |
Expression and recovery of biologically active recombinant Apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds
CL Nykiforuk, Y Shen, EW Murray, JG Boothe, D Busseuil, E Rhéaume, JC Tardif, A Reid, MM Moloney |
Plant Biotechnology Journal | 2011 |
ETC-216 for coronary artery disease
SJ Nicholls, K Uno, Y Kataoka, SE Nissen |
Expert Opinion on Biological Therapy | 2011 |
Manufacturing and shelf stability of reconstituted high-density lipoprotein for infusion therapy
JS Kim, Y Kang, KH Son, SM Choi, KY Kim |
Biotechnology and Bioprocess Engineering | 2011 |
Adeno-associated Virus Serotype 8 ApoA-I Gene Transfer Reduces Progression of Atherosclerosis in ApoE-KO Mice: Comparison of Intramuscular and Intravenous Administration
G Cimmino, C Giannarelli, W Chen, M Alique, CG Santos-Gallego, V Fuster, RJ Hajjar, CE Walsh, JJ Badimon |
Journal of Cardiovascular Pharmacology | 2011 |
Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins
S Imaizumi, M Navab, C Morgantini, C Charles-Schoeman, F Su, F Gao, M Kwon, E Ganapathy, D Meriwether, R Farias-Eisner, AM Fogelman, ST Reddy |
Circulation Journal | 2011 |
Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits
MR Ozaki, EA de Almeida |
Experimental and Toxicologic Pathology | 2011 |
HDL-C: Role as a risk modifier
P Barter |
Atherosclerosis Supplements | 2011 |
Growth Hormone
VS Herman-Bonert, S Melmed |
The Pituitary | 2011 |
An integrated approach for the mechanisms responsible for atherosclerotic plaque regression
AA Francis, GN Pierce |
Experimental & Clinical Cardiology | 2011 |
Preventive Cardiology: Companion to Braunwald's Heart Disease
PN Hopkins |
Preventive Cardiology: Companion to Braunwald's Heart Disease | 2011 |
Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type)
B Ibanez, C Giannarelli, G Cimmino, CG Santos-Gallego, M Alique, A Pinero, G Vilahur, V Fuster, L Badimon, JJ Badimon |
Atherosclerosis | 2011 |
Case Studies for Complementary Therapists
K Galvin, M Bishop |
Case Studies for Complementary Therapists | 2011 |
The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations
L Tian, M Fu |
Journal of Endocrinological Investigation | 2011 |
Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia
R Li, H Chao, KW Ko, S Cormier, C Dieker, EA Nour, S Wang, L Chan, K Oka |
Journal of genetic syndrome & gene therapy | 2011 |
Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins
S Imaizumi, M Navab, C Morgantini, C Charles-Schoeman, F Su, F Gao, M Kwon, E Ganapathy, D Meriwether, R Farias-Eisner, AM Fogelman, ST Reddy |
Circulation Journal | 2011 |
Atherosclerosis and Thrombosis: Insights from Large Animal Models
G Vilahur, T Padro, L Badimon |
Journal of Biomedicine and Biotechnology | 2011 |
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, Watts GF |
European Heart Journal | 2011 |
Future Therapeutic Directions in Reverse Cholesterol Transport
AV Khera, DJ Rader |
Current Atherosclerosis Reports | 2010 |
5A, an Apolipoprotein A-I Mimetic Peptide, Attenuates the Induction of House Dust Mite-Induced Asthma
X Yao, C Dai, K Fredriksson, PK Dagur, JP McCoy, X Qu, ZX Yu, KJ Keeran, GJ Zywicke, MJ Amar, AT Remaley, SJ Levine |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease
PP Toth |
Current Cardiology Reports | 2010 |
Structure and Function of HDL Mimetics
M Navab, I Shechter, GM Anantharamaiah, ST Reddy, BJ Lenten, AM Fogelman |
Arteriosclerosis, thrombosis, and vascular biology | 2010 |
Cholesterol in β-cell Dysfunction: The Emerging Connection Between HDL Cholesterol and Type 2 Diabetes
LR Brunham, JK Kruit, MR Hayden, CB Verchere |
Current Diabetes Reports | 2010 |
Cholesteryl ester transfer protein and its inhibition
O Weber, H Bischoff, C Schmeck, MF Böttcher |
Cellular and Molecular Life Sciences | 2010 |
Atherosclerosis regression and high-density lipoproteins
JM Lee, RP Choudhury |
Expert Review of Cardiovascular Therapy | 2010 |
HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis
EM Tsompanidi, MS Brinkmeier, EH Fotiadou, SM Giakoumi, KE Kypreos |
Atherosclerosis | 2010 |
Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability
Z Chen, M Ichetovkin, M Kurtz, E Zycband, D Kawka, J Woods, X He, AS Plump, E Hailman |
Lipids in Health and Disease | 2010 |
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
JM Woo, Z Lin, M Navab, CV Dyck, Y Trejo-Lopez, KM Woo, H Li, LW Castellani, X Wang, N Iikuni, OJ Rullo, H Wu, AL Cava, AM Fogelman, AJ Lusis, BP Tsao |
Arthritis Research & Therapy | 2010 |
Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model
WS Speidl, G Cimmino, B Ibanez, S Elmariah, R Hutter, MJ Garcia, V Fuster, ME Goldman, JJ Badimon |
European Heart Journal | 2010 |
Incremento de las HDL como arma terapéutica en la aterotrombosis
JJ Badimón, B Ibáñez |
Revista Española de Cardiología | 2010 |
Importancia del colesterol HDL en la aterotrombosis. ¿De dónde venimos? ¿Hacia dónde vamos?
JJ Badimón, CG Santos-Gallego, L Badimón |
Revista Española de Cardiología | 2010 |
Recombinant High-Density Lipoprotein Formulations
E Vucic, RS Rosenson |
Current Atherosclerosis Reports | 2010 |
Quantification of plaque neovascularization using contrast ultrasound: a histologic validation
D Moguillansky, X Leng, A Carson, L Lavery, A Schwartz, X Chen, FS Villanueva |
European Heart Journal | 2010 |
Lessons from Coronary Intravascular Ultrasound on the Importance of Raising High-Density Lipoprotein Cholesterol
SJ Nicholls, K Uno, EM Tuzcu, SE Nissen |
Current Atherosclerosis Reports | 2010 |
A pathobiologic link between risk factors profile and morphological markers of carotid instability
A Mauriello, GM Sangiorgi, R Virmani, S Trimarchi, DR Holmes, FD Kolodgie, DG Piepgras, G Piperno, D Liotti, J Narula, P Righini, A Ippoliti, LG Spagnoli |
Atherosclerosis | 2010 |
Findings of clinical trials that evaluate the impact of medical therapies on progression of atherosclerosis
A Lavoie, K Uno, O Bayturan, SJ Nicholls |
Current Medical Research and Opinion | 2010 |
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
R Waksman, R Torguson, KM Kent, AD Pichard, WO Suddath, LF Satler, BD Martin, TJ Perlman, JA Maltais, NJ Weissman, PJ Fitzgerald, HB Brewer |
Journal of the American College of Cardiology | 2010 |
Anti-inflammatory effects of apolipoprotein A-I in the rabbit
S Patel, BA di Bartolo, S Nakhla, AK Heather, TW Mitchell, W Jessup, DS Celermajer, PJ Barter, KA Rye |
Atherosclerosis | 2010 |
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
JC Tardif |
Journal of Clinical Lipidology | 2010 |
Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10 residue Class G* Apolipoprotein J peptide using solution NMR#
VK Mishra, MN Palgunachari, JS Hudson, R Shin, TD Keenum, NR Krishna, GM Anantharamaiah |
Biochimica et Biophysica Acta | 2010 |
Lipoproteínas de alta densidad y regresión de la arteriosclerosis: desde la teoría hasta la imagen
B Ibáñez |
Clínica e Investigación en Arteriosclerosis | 2010 |
Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis
JD Smith |
Current opinion in investigational drugs (London, England : 2000) | 2010 |
The HDL Handbook
NJ Hime |
The HDL Handbook | 2010 |
Increasing High-Density Lipoprotein as a Therapeutic Target in Atherothrombotic Disease
JJ Badimón, B Ibáñez |
Revista Española de Cardiología (English Edition) | 2010 |
Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits
BH Cho, JR Park, MT Nakamura, BM Odintsov, MA Wallig, BH Chung |
Experimental biology and medicine (Maywood, N.J.) | 2010 |
Biochemical characterization of cholesteryl ester transfer protein inhibitors
M Ranalletta, KK Bierilo, Y Chen, D Milot, Q Chen, E Tung, C Houde, NH Elowe, M Garcia-Calvo, G Porter, S Eveland, B Frantz-Wattley, M Kavana, G Addona, P Sinclair, C Sparrow, EA O'Neill, KS Koblan, A Sitlani, B Hubbard, TS Fisher |
Journal of lipid research | 2010 |
Blood Rheology and the Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Ratio in Dyslipidaemic and Normolipidaemic Subjects
T Machida, H Sumino, M Fukushima, N Kotajima, H Amagai, M Murakami |
J INT MED RES | 2010 |
High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease
EJ Schaefer |
2010 | |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Regulation of Bile Acid and Cholesterol Metabolism by PPARs
T Li, JY Chiang |
PPAR Research | 2009 |
The 6th Annual World Congress on the Insulin Resistance Syndrome
ZT Bloomgarden |
Diabetes care | 2009 |
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
FM Sacks, LL Rudel, A Conner, H Akeefe, G Kostner, T Baki, G Rothblat, M la Llera-Moya, B Asztalos, T Perlman, C Zheng, P Alaupovic, JA Maltais, HB Brewer |
Journal of lipid research | 2009 |
Effect of lipid-modifying therapies on the functional quality of high-density lipoproteins: implications for drug development
MN Duong, SJ Nicholls |
Expert Opinion on Drug Discovery | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
Paraoxonases in Inflammation, Infection, and Toxicology
ST Reddy |
Paraoxonases in Inflammation, Infection, and Toxicology | 2009 |
HDL as a Biomarker, Potential Therapeutic Target, and Therapy
M Navab, GM Anantharamaiah, ST Reddy, BJ van Lenten, AM Fogelman |
Diabetes | 2009 |
The metabolism and anti-atherogenic properties of HDL
KA Rye, CA Bursill, G Lambert, F Tabet, PJ Barter |
Journal of lipid research | 2009 |
The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease
P Meyer, A Nigam, M Marcil, JC Tardif |
Current Atherosclerosis Reports | 2009 |
Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries
SJ Nicholls |
Current Opinion in Lipidology | 2009 |
Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review
DR Chirovsky, V Fedirko, Y Cui, V Sazonov, P Barter |
European Journal of Cardiovascular Prevention & Rehabilitation | 2009 |
Antilipogenic effect of green tea extract in C57BL/6J-Lepob/obmice
HJ Kim, SM Jeon, MK Lee, UJ Jung, SK Shin, MS Choi |
Phytotherapy Research | 2009 |
Novel Therapies for Increasing Serum Levels of HDL
PP Toth |
Endocrinology & Metabolism Clinics of North America | 2009 |
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions
EV Craeyveld, J Lievens, F Jacobs, Y Feng, J Snoeys, BD Geest |
Gene Therapy | 2009 |
Promoting Mechanisms of Vascular Health
PR Moreno, J Sanz, V Fuster |
Journal of the American College of Cardiology | 2009 |
Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels
DJ Hausenloy, DM Yellon |
Current Opinion in Cardiology | 2009 |
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
JM Lee, MD Robson, LM Yu, CC Shirodaria, C Cunnington, I Kylintireas, JE Digby, T Bannister, A Handa, F Wiesmann, PN Durrington, KM Channon, S Neubauer, RP Choudhury |
Journal of the American College of Cardiology | 2009 |
Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?
G Fabbri, AP Maggioni |
Advances in Therapy | 2009 |
High-Density Lipoprotein and Progression Rate of Atherosclerosis in Intravascular Ultrasound Trials
SJ Nicholls |
The American Journal of Cardiology | 2009 |
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
FM Sacks, LL Rudel, A Conner, H Akeefe, G Kostner, T Baki, G Rothblat, M la Llera-Moya, B Asztalos, T Perlman, C Zheng, P Alaupovic, JA Maltais, HB Brewer |
Journal of lipid research | 2009 |
Contemporary Interventional Ultrasonography in Urology
O Ukimura, IS Gill |
2009 | |
HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications
AT Remaley, M Amar, D Sviridov |
Expert Review of Cardiovascular Therapy | 2008 |
Atherosclerosis regression
JM Lee, AC Lindsay, I Kylintireas, RP Choudhury |
Current Treatment Options in Cardiovascular Medicine | 2008 |
Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano)
G Cimmino, B Ibanez, G Vilahur, WS Speidl, V Fuster, L Badimon, JJ Badimon |
Journal of Cellular and Molecular Medicine | 2008 |
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LT Bloedon, R Dunbar, D Duffy, P Pinell-Salles, R Norris, BJ DeGroot, R Movva, M Navab, AM Fogelman, DJ Rader |
Journal of lipid research | 2008 |
HDL Metabolism and CETP Inhibition
RS Barkowski, WH Frishman |
Cardiology in Review | 2008 |
Acute effects of high-density lipoproteins: biochemical basis and clinical findings
G Chiesa, C Parolini, CR Sirtori |
Current Opinion in Cardiology | 2008 |
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
NK Kapur, D Ashen, RS Blumenthal |
Vascular Health and Risk Management | 2008 |
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides
BJ van Lenten, M Navab, GM Anantharamaiah, GM Buga, ST Reddy, AM Fogelman |
Current opinion in investigational drugs (London, England : 2000) | 2008 |
Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides
R Yu, B Yekta, L Vakili, N Gharavi, M Navab, D Marelli, A Ardehali |
Current Atherosclerosis Reports | 2008 |
High-density lipoprotein/apolipoprotein A-I infusion therapy
JC Tardif, T Heinonen, S Noble |
Current Atherosclerosis Reports | 2008 |
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus
LJ Rijzewijk, RW van der Meer, JW Smit, M Diamant, JJ Bax, S Hammer, JA Romijn, A Roos, HJ Lamb |
Journal of the American College of Cardiology | 2008 |
The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis
M Navab, GM Anantharamaiah, AM Fogelman |
Trends in Cardiovascular Medicine | 2008 |
Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia
M Vergeer, JJ Kastelein |
Nature Clinical Practice Cardiovascular Medicine | 2008 |
High-density lipoprotein and atheroma monitoring
SJ Nicholls, EM Tuzcu |
Current Opinion in Cardiology | 2008 |
Cholesteryl Ester Transfer Protein Inhibition for Coronary Heart Disease Prevention: Real Hope or Despair?
WH Frishman, RS Barkowski |
The American Journal of Medicine | 2008 |
Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease
CM Rasnake, PR Trumbo, TM Heinonen |
Nutrition Reviews | 2008 |
Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial
HR Underhill, C Yuan, XQ Zhao, LW Kraiss, DL Parker, T Saam, B Chu, N Takaya, F Liu, NL Polissar, B Neradilek, JS Raichlen, VA Cain, JC Waterton, W Hamar, TS Hatsukami |
American Heart Journal | 2008 |
Synthetic HDL as a new treatment for atherosclerosis regression: Has the time come?
P Conca, G Franceschini |
Nutrition Metabolism and Cardiovascular Diseases | 2008 |
Comprehensive Lipid Management Versus Aggressive Low-Density Lipoprotein Lowering to Reduce Cardiovascular Risk
RH Knopp, P Paramsothy, B Atkinson, A Dowdy |
The American Journal of Cardiology | 2008 |
Diabetes y enfermedad cardiovascular
V Fuster, B Ibáñez |
Revista Española de Cardiología Suplementos | 2008 |
Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis
B Ibanez, G Cimmino, J Bénézet-Mazuecos, CG Santos-Gallego, A Pinero, S Prat-González, WS Speidl, V Fuster, MJ García, J Sanz, JJ Badimon |
Atherosclerosis | 2008 |
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis
B Ibanez, G Vilahur, G Cimmino, WS Speidl, A Pinero, BG Choi, MU Zafar, CG Santos-Gallego, B Krause, L Badimon, V Fuster, JJ Badimon |
Journal of the American College of Cardiology | 2008 |
HDL-cholesterol: Is it really good?
CG Santos-Gallego, B Ibanez, JJ Badimon |
Biochemical Pharmacology | 2008 |
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LA Bloedon, R Dunbar, D Duffy, P Pinell-Salles, R Norris, BJ DeGroot, R Movva, M Navab, AM Fogelman, DJ Rader |
Journal of lipid research | 2008 |
The metabolism and anti-atherogenic properties of HDL
KA Rye, CA Bursill, G Lambert, F Tabet, PJ Barter |
Journal of lipid research | 2008 |
Differences in DBA/1J and DBA/2J reveal lipid QTL genes
IM Stylianou, SR Langley, K Walsh, Y Chen, C Revenu, B Paigen |
Journal of lipid research | 2008 |
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in mice
T Juan, MM Véniant, J Helmering, P Babij, DM Baker, MA Damore, MB Bass, T Gyuris, M Chhoa, CM Li, C Ebeling, J Amato, GA Carlson, DJ Lloyd |
Journal of lipid research | 2008 |
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto |
2008 | |
Comparison of coronary plaque composition among patients with acute coronary syndrome and stable coronary artery disease:
X LI, C HUANG, T WANG, S ZHUANG, H ZHOU, B TIAN |
Chinese Medical Journal | 2008 |
Modifying the anti-inflammatory effects of high-density lipoprotein
BJ Ansell, GC Fonarow, M Navab, AM Fogelman |
Current Atherosclerosis Reports | 2007 |
HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease
HB Brewer |
Current Cardiology Reports | 2007 |
Emerging HDL-based therapies for atherothrombotic vascular disease
PK Shah |
Current Treatment Options in Cardiovascular Medicine | 2007 |
Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides
M Gomaraschi, L Calabresi, G Rossoni, S Iametti, G Franceschini, JA Stonik, AT Remaley |
The Journal of pharmacology and experimental therapeutics | 2007 |
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.
Barter PJ, Puranik R, Rye KA |
Current Cardiology Reports | 2007 |
FULL TEXT Chapter 1: Introduction
&NA; |
European Journal of Cardiovascular Prevention & Rehabilitation | 2007 |
Molecular Mechanisms Responsible for the Anti-Inflammatory and Protective Effect of High-Density Lipoprotein on the Endothelium
GD Norata, AL Catapano |
High Blood Pressure & Cardiovascular Prevention | 2007 |
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease
PJ Barter, R Puranik, KA Rye |
Current Cardiology Reports | 2007 |
Exploring the natural history of atherosclerosis with intravascular ultrasound
SJ Nicholls, J Andrews, KW Moon |
Expert Review of Cardiovascular Therapy | 2007 |
Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
D Liao, X Yang, H Wang |
Clinical Chemistry and Laboratory Medicine | 2007 |
Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?
SJ Nicholls, EM Tuzcu, SE Nissen |
Current Atherosclerosis Reports | 2007 |
Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol
PP Toth |
Current Atherosclerosis Reports | 2007 |
Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: In vivo demonstration by high-resolution MRI
R Corti, J Osende, R Hutter, JF Viles-Gonzalez, U Zafar, C Valdivieso, G Mizsei, JT Fallon, V Fuster, JJ Badimon |
Atherosclerosis | 2007 |
Vascular inflammation
V Fuster, J Sanz |
Journal of the American Society of Hypertension | 2007 |
New targets of high-density lipoprotein therapy
SJ Nicholls, SE Nissen |
Current Opinion in Lipidology | 2007 |
Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound
SR Kalidindi, EM Tuzcu, SJ Nicholls |
International Journal of Clinical Practice | 2007 |
Molecular Mechanisms Responsible for the Anti-Inflammatory and Protective Effect of High-Density Lipoprotein on the Endothelium:
GD Norata, AL Catapano |
High Blood Pressure & Cardiovascular Prevention | 2007 |
New targets of high-density lipoprotein therapy:
SJ Nicholls, SE Nissen |
Current Opinion in Lipidology | 2007 |
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
GM Anantharamaiah, VK Mishra, DW Garber, G Datta, SP Handattu, MN Palgunachari, M Chaddha, M Navab, ST Reddy, JP Segrest, AM Fogelman |
Journal of lipid research | 2007 |
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
LA Morehouse, ED Sugarman, PA Bourassa, TM Sand, F Zimetti, F Gao, GH Rothblat, AJ Milici |
Journal of lipid research | 2007 |
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects
CJ Fielding |
2007 | |
Aggressive Very Low-Density Lipoprotein (VLDL) and LDL Lowering by Gene Transfer of the VLDL Receptor Combined with a Low-Fat Diet Regimen Induces Regression and Reduces Macrophage Content in Advanced Atherosclerotic Lesions in LDL Receptor-Deficient Mice
ED MacDougall, F Kramer, P Polinsky, S Barnhart, B Askari, F Johansson, R Varon, ME Rosenfeld, K Oka, L Chan, SM Schwartz, KE Bornfeldt |
The American Journal of Pathology | 2006 |
The rationale for using apoA-I as a clinical marker of cardiovascular risk
PJ Barter, KA Rye |
Journal of Internal Medicine | 2006 |
HDL and endothelial function: from molecular mechanisms to clinical observations
GD Norata, S Raselli, AL Catapano |
Future Lipidology | 2006 |
Protection of Endothelial Function: Targets for Nutritional and Pharmacological Interventions
I Sudano, LE Spieker, F Hermann, A Flammer, R Corti, G Noll, TF L??scher |
Journal of Cardiovascular Pharmacology | 2006 |
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases
L Calabresi, CR Sirtori, R Paoletti, G Franceschini |
Current Atherosclerosis Reports | 2006 |
High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells
A Cucina, MP Scavo, L Muzzioli, P Coluccia, S Ceccarini, A Fuso, A Cavallaro |
Atherosclerosis | 2006 |
Estrogen regulation of the scavenger receptor class B gene: Anti-atherogenic or steroidogenic, is there a priority?
D Lopez, MP McLean |
Molecular and Cellular Endocrinology | 2006 |
High-density lipoproteins: an emerging target in the prevention of cardiovascular disease
BA Cutri, NJ Hime, SJ Nicholls |
Cell Research | 2006 |
High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease
M Gomaraschi, L Calabresi, G Franceschini |
Expert Opinion on Therapeutic Targets | 2006 |
HDL inflammation and atherosclerosis: current and future perspectives
T Sampietro, F Bigazzi, M Puntoni, A Bionda |
Future Cardiology | 2006 |
HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigm
PK Shah |
Future Lipidology | 2006 |
Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets
JM Lee, RP Choudhury |
Heart (British Cardiac Society) | 2006 |
Evaluación de la progresión y la regresión de la aterosclerosis coronaria mediante ecografía intravascular. ¿Un nuevo cambio de paradigma?
SJ Nicholls, I Sipahi, EM Tuzcu |
Revista Española de Cardiología | 2006 |
Therapeutic use of the high-density lipoprotein protein and peptides
M Marchesi, CR Sirtori |
Expert Opinion on Investigational Drugs | 2006 |
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention
M Navab, GM Anantharamaiah, ST Reddy, AM Fogelman |
Nature Clinical Practice Cardiovascular Medicine | 2006 |
Application of intravascular ultrasound in anti-atherosclerotic drug development
SJ Nicholls, I Sipahi, P Schoenhagen, T Crowe, EM Tuzcu, SE Nissen |
Nature Reviews Drug Discovery | 2006 |
Relationship between the concentration and antiatherogenic activity of high-density lipoproteins
PJ Barter, KA Rye |
Current Opinion in Lipidology | 2006 |
Potential clinical utility of high-density lipoprotein-mimetic peptides
M Navab, GM Anantharamaiah, ST Reddy, BJ van Lenten, G Datta, D Garber, AM Fogelman |
Current Opinion in Lipidology | 2006 |
HDL: The ‘new’ target of cardiovascular medicine
T Sampietro, F Bigazzi, BD Pino, M Puntoni, A Bionda |
International Journal of Cardiology | 2006 |
Assessment of Progression and Regression of Coronary Atherosclerosis by Intravascular Ultrasound. A New Paradigm Shift?
SJ Nicholls, I Sipahi, EM Tuzcu |
Revista Española de Cardiología (English Edition) | 2006 |
Complex Genetic Architecture Revealed by Analysis of High-Density Lipoprotein Cholesterol in Chromosome Substitution Strains and F 2 Crosses
IM Stylianou, SW Tsaih, K DiPetrillo, N Ishimori, R Li, B Paigen, G Churchill |
Genetics | 2006 |
High-density lipoprotein function recent advances
BJ Ansell, KE Watson, AM Fogelman, M Navab, GC Fonarow |
Journal of the American College of Cardiology | 2005 |
Nonpharmacologic Approaches for the Treatment of Hyperlipidemia
T Kermani, WH Frishman |
Cardiology in Review | 2005 |
Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: Comparison with probucol
SM Jeon, YB Park, OS Kwon, TL Huh, WH Lee, KM Do, T Park, MS Choi |
Journal of Biochemical and Molecular Toxicology | 2005 |
High-density lipoprotein cholesterol in the cardiovascular equation: Does the “good” still count?
AA Alsheikh-Ali, JT Kuvin, RH Karas |
Atherosclerosis | 2005 |
Atherothrombosis and High-Risk Plaque
V Fuster, PR Moreno, ZA Fayad, R Corti, JJ Badimon |
Journal of the American College of Cardiology | 2005 |
High-density lipoproteins as therapeutic targets
SJ Nicholls, KA Rye, PJ Barter |
Current Opinion in Lipidology | 2005 |
BHUx: A Patent Polyherbal Formulation to Prevent Atherosclerosis
YB Tripathi, BK Singh, RS Pandey, M Kumar |
Evidence-based complementary and alternative medicine : eCAM | 2005 |
Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence
JR Nofer, M Walter, G Assmann |
Expert Review of Cardiovascular Therapy | 2005 |
Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?
AS Wierzbicki |
Current Medical Research and Opinion | 2005 |
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging
R Corti, V Fuster, ZA Fayad, SG Worthley, G Helft, WF Chaplin, J Muntwyler, JF Viles-Gonzalez, J Weinberger, DA Smith, G Mizsei, JJ Badimon |
Journal of the American College of Cardiology | 2005 |
Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium
GD Norata, AL Catapano |
Vascular Health and Risk Management | 2005 |
Anti-Inflammatory Properties of HDL
BJ Ansell, M Navab, KE Watson, GC Fonarow, AM Fogelman |
Reviews in Endocrine and Metabolic Disorders | 2004 |
Oral supplement of six selective amino acids arrest progression renal failure in uremic patients
H Yatzidis |
International Urology and Nephrology | 2004 |
Metabolic abnormalities: high-density lipoproteins
P Barter |
Endocrinology & Metabolism Clinics of North America | 2004 |
A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease
GK Hovingh, A Brownlie, RJ Bisoendial, MP Dube, JH Levels, W Petersen, RP Dullaart, ES Stroes, AH Zwinderman, E Groot, MR Hayden, JA Kuivenhoven, JJ Kastelein |
Journal of the American College of Cardiology | 2004 |
Genetic determinants of low high-density lipoprotein cholesterol
M Miller, M Zhan |
Current Opinion in Cardiology | 2004 |
Therapeutic approaches to raising plasma HDL-cholesterol levels
MM Thompson, SC Reed, GW Cockerill |
Nature Clinical Practice Cardiovascular Medicine | 2004 |
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular disease
GF Watts, JR Burnett |
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists | 2004 |
Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex
S Kaul, B Coin, A Hedayiti, J Yano, B Cercek, KY Chyu, PK Shah |
Journal of the American College of Cardiology | 2004 |
New aspects in the pathogenesis of diabetic atherothrombosis
PR Moreno, V Fuster |
Journal of the American College of Cardiology | 2004 |
Conjugated linoleic acid isomer effects in atherosclerosis: Growth and regression of lesions
D Kritchevsky, SA Tepper, S Wright, SK Czarnecki, TA Wilson, RJ Nicolosi |
Lipids | 2004 |
Simvastatin potenciates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL
J Martı́nez-González, I Escudero, L Badimon |
Atherosclerosis | 2004 |
Treating low HDL—From bench to bedside
DS Ng |
Clinical Biochemistry | 2004 |
Treatment of Vulnerable Plaques : Current and Future Strategies
D Brieger, SB Freedman, L Kritharides, H Lowe |
High-Risk Atherosclerotic Plaques Mechanisms Imaging Models and Therapy | 2004 |
The Antioxidant Function of High Density Lipoproteins: A New Paradigm in Atherosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat |
Revista Española de Cardiología (English Edition) | 2004 |
Función antioxidante de las lipoproteínas de alta densidad: un nuevo paradigma en la arteriosclerosis
M Tomás, G Latorre, M Sentí, J Marrugat |
Revista Española de Cardiología | 2004 |
Importancia del colesterol ligado a lipoproteínas de alta densidad (cHDL) en la prevención del riesgo cardiovascular. Recomendaciones del Foro HDL
A J.F., FC A., GS P., HM A., MR A., M J., P L.F., J Pedro-Botet, PJ F., P G., X Pintó, I Plaza, J Rubiés-Prat |
Clínica e Investigación en Arteriosclerosis | 2004 |
Atherogenesis and vascular calcification in mice expressing the human LPA gene
PA Teivainen, KA Eliassen, K Berg, K Torsdalen, A Svindland |
Pathophysiology | 2004 |
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
M Navab, GM Ananthramaiah, ST Reddy, BJ van Lenten, BJ Ansell, GC Fonarow, K Vahabzadeh, S Hama, G Hough, N Kamranpour, JA Berliner, AJ Lusis, AM Fogelman |
Journal of lipid research | 2004 |
Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention: Recommendations of the HDL Forum1
JF Ascaso, A Fernndez-Cruz, PG Santos, AH Mijares, AM Rojas, J Milln, LF Pallardo, J Pedro-Botet, F Prez-Jimnez, G Pa, X Pint, I Plaza, J Rubis-Prat |
American Journal Cardiovascular Drugs | 2004 |
Comparative effects of lipid-lowering therapies
MH Davidson, PP Toth |
Progress in Cardiovascular Diseases | 2004 |
Optimal Therapy of Low Levels of High Density Lipoprotein-Cholesterol:
ML Kashyap, S Tavintharan, VS Kamanna |
American Journal Cardiovascular Drugs | 2003 |
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
GD Backer, E Ambrosioni, K Broch-Johnsen, C Brotons, R Cifkova, J Dallongeville, S Ebrahim, O Faergeman, I Graham, G Mancia, VM Cats, K Orth-Gom??r, J Perk, K Py??r??l??, JL Rodicio, S Sans, V Sansoy, U Sechtem, S Silber, T Thomsen, D Wood |
European Journal of Cardiovascular Prevention and Rehabilitation | 2003 |
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
SE Borggreve, R Vries, RP Dullaart |
European Journal of Clinical Investigation | 2003 |
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
P Barter, J Kastelein, A Nunn, R Hobbs |
Atherosclerosis | 2003 |
Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC
I Escudero, J Martinez-Gonzalez, R Alonso, P Mata, L Badimon |
European Journal of Clinical Investigation | 2003 |
Induction of Fatal Inflammation in LDL Receptor and ApoA-I Double-Knockout Mice Fed Dietary Fat and Cholesterol
M Zabalawi, S Bhat, T Loughlin, MJ Thomas, E Alexander, M Cline, B Bullock, M Willingham, MG Sorci-Thomas |
The American Journal of Pathology | 2003 |
Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes
JF Viles-Gonzalez, V Fuster, R Corti, JJ Badimon |
Current Opinion in Cardiology | 2003 |
Apolipoprotein A-IMilano: current perspectives
G Chiesa, CR Sirtori |
Current Opinion in Lipidology | 2003 |
new understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging
R Corti, V Fuster |
The American Journal of Cardiology | 2003 |
Effect of baseline levels on response of high-density lipoprotein cholesterol to hypolipidemic treatment
GD Kolovou, DC Daskalova, II Petropoulos, KK Anagnostopoulou, HI Bilianou, ND Pilatis, AN Pavlidis, DV Cokkinos |
The American Journal of Cardiology | 2003 |
Regulation of reverse cholesterol transport and clinical implications
DJ Rader |
The American Journal of Cardiology | 2003 |
Papel de los factores de riesgo en la trombogenicidad sanguínea y los síndromes coronarios agudos
A Sambola, V Fuster, JJ Badimon |
Revista Española de Cardiología | 2003 |
Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation
S Rosas, P Szapary, DJ Rader |
Cardiology Clinics | 2003 |
Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions
Yoshikazu Ishimoto, Katsutoshi Yamada, Shigenori Yamamoto, Takashi Ono, Mitsuru Notoya, Kohji Hanasaki |
Biochimica et Biophysica Acta | 2003 |
Phosphatidylinositol promotes cholesterol transport and excretion
JW Burgess, J Boucher, TA Neville, P Rouillard, C Stamler, S Zachariah, DL Sparks |
Journal of lipid research | 2003 |
Infections and the Cardiovascular System: New Perspectives
IW Fong |
2003 | |
High-Density Lipoproteins as an Emerging Therapeutic Target for Atherosclerosis
DJ Rader |
Journal of the American Medical Association | 2003 |
Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults
Y Hata, H Mabuchi, Y Saito, H Itakura, G Egusa, H Ito, T Teramoto, M Tsushima, N Tada, S Oikawa, N Yamada, S Yamashita, N Sakuma, J Sasaki |
Journal of Atherosclerosis and Thrombosis | 2002 |
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer, B Kehrel, M Fobker, B Levkau, G Assmann, A Eckardstein |
Atherosclerosis | 2002 |
Beyond LDL-C – The Importance of Raising HDL-C
AS Wierzbicki, DP Mikhailidis |
Current Medical Research and Opinion | 2002 |
Lack of inhibitory effect of HDL on TNFα-induced adhesion molecule expression in human aortic endothelial cells
WJ Zhang, R Stocker, MR McCall, TM Forte, B Frei |
Atherosclerosis | 2002 |
Anti-Atherosclerotic Effect of β-Blocker with Nitric Oxide–Releasing Action on the Severe Atherosclerosis
NK Thakur, T Hayashi, D Sumi, H Kano, H Matsui-Hirai, T Tsunekawa, A Iguchi |
Journal of Cardiovascular Pharmacology | 2002 |
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice
M Kawashiri, YZ Zhang, E Puré, DJ Rader |
Atherosclerosis | 2002 |
Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E
YX Wang, B Martin-McNulty, LY Huw, V Cunha, J Post, J Hinchman, R Vergona, ME Sullivan, W Dole, K Kauser |
Atherosclerosis | 2002 |
Biologic aspects of vulnerable plaque
R Corti, JJ Badimon |
Current Opinion in Cardiology | 2002 |
The Mikamo Lecture 2002
V Fuster, R Corti, JJ Badimon |
Circulation Journal | 2002 |
High-density lipoproteins and atherosclerosis
DJ Rader |
The American Journal of Cardiology | 2002 |
The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations
FM Sacks |
The American Journal of Cardiology | 2002 |
Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks
G Chiesa, E Monteggia, M Marchesi, P Lorenzon, M Laucello, V Lorusso, CD Mario, E Karvouni, RS Newton, CL Bisgaier, G Franceschini, CR Sirtori |
Circulation research | 2002 |
High-density lipoprotein restores endothelial function in hypercholesterolemic men
LE Spieker, I Sudano, D Hürlimann, PG Lerch, MG Lang, C Binggeli, R Corti, F Ruschitzka, TF Lüscher, G Noll |
Circulation | 2002 |
Fisiopatología de la enfermedad aterotrombótica coronaria
JJ Badimon, B Badimon, V Fuster |
Clínica e Investigación en Arteriosclerosis | 2002 |
HDL therapy for the acute treatment of atherosclerosis
RS Newton, BR Krause |
Atherosclerosis Supplements | 2002 |
Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL
B Angelin, P Parini, M Eriksson |
Atherosclerosis Supplements | 2002 |
HDL in risk prediction and its direct and indirect involvement in atherogenesis
P Durrington |
Atherosclerosis Supplements | 2002 |
Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol
M Navab, GM Anantharamaiah, S Hama, DW Garber, M Chaddha, G Hough, R Lallone, AM Fogelman |
Circulation | 2002 |
Paraoxonase (PON1) in Health and Disease
LG Costa, CE Furlong |
2002 | |
Antioxidative Activity of Green Tea Polyphenol in Cholesterol-Fed Rats
T Yokozawa, T Nakagawa, K Kitani |
Journal of Agricultural and Food Chemistry | 2002 |
Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells
A Stannard |
Atherosclerosis | 2001 |
Cholesteryl ester transfer protein, high density lipoprotein and arterial disease
PJ Barter, KA Rye |
Current Opinion in Lipidology | 2001 |
CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation
DL Feldman, WK Sawyer, MR Jeune, TC Mogelesky, JV Linden-Reed, MF Prescott |
Atherosclerosis | 2001 |
New Understanding of Atherosclerosis (Clinically and Experimentally) with Evolving MRI Technology in Vivo
R Corti, V Fuster, JJ Badimon, R Hutter, ZA Fayad |
Annals of the New York Academy of Sciences | 2001 |
Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport
RP Dullaart, A Tol |
Diabetic Medicine | 2001 |
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu |
Heart Physiology and Pathophysiology | 2001 |
High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock
GW Cockerill, MC McDonald, H Mota-Filipe, S Cuzzocrea, NE Miller, C Thiemermann |
The FASEB Journal | 2001 |
High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects
PP Toth |
Disease-a-Month | 2001 |
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis
DW Garber, G Datta, M Chaddha, MN Palgunachari, SY Hama, M Navab, AM Fogelman, JP Segrest, GM Anantharamaiah |
Journal of lipid research | 2001 |
Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E–deficient mouse in a novel transplantation model
ED Reis, J Li, ZA Fayad, JX Rong, D Hansoty, JG Aguinaldo, JT Fallon, EA Fisher |
Journal of Vascular Surgery | 2001 |
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
PK Shah, S Kaul, J Nilsson, B Cercek |
Circulation | 2001 |
Paraoxonase and Atherosclerosis
PN Durrington, B Mackness, MI Mackness |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E-Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content
JX Rong, J Li, ED Reis, RP Choudhury, HM Dansky, VI Elmalem, JT Fallon, JL Breslow, EA Fisher |
Circulation | 2001 |
Elevation of Plasma High-Density Lipoprotein Concentration Reduces Interleukin-1–Induced Expression of E-Selectin in an In Vivo Model of Acute Inflammation
GW Cockerill, TY Huehns, A Weerasinghe, C Stocker, PG Lerch, NE Miller, DO Haskard |
Circulation | 2001 |
Does Therapeutic Intervention Achieve Slowing of Progression or Bona Fide Regression of Atherosclerotic Lesions?
Y Stein, O Stein |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Inhibition of Cholesterol Efflux by 7-Ketocholesterol: Comparison between Cells, Plasma Membrane Vesicles, and Liposomes as Cholesterol Donors
K Gaus, RT Dean, L Kritharides, W Jessup |
Biochemistry | 2001 |
In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
CC Hedrick, LW Castellani, H Wong, AJ Lusis |
Journal of lipid research | 2001 |
Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux
PG Yancey, WG Jerome |
Journal of lipid research | 2001 |
Postprandial lipemia and coronary risk
W Patsch, H Esterbauer, B Föger, JR Patsch |
Current Atherosclerosis Reports | 2000 |
High-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis
M Kawashiri, C Maugeais, DJ Rader |
Current Atherosclerosis Reports | 2000 |
The role of plaque rupture and thrombosis in coronary artery disease
AG Zaman, G Helft, SG Worthley, JJ Badimon |
Atherosclerosis | 2000 |
Focus on HDL: a new treatment paradigm for athero-thrombotic vascular disease
PK Shah |
Expert Opinion on Investigational Drugs | 2000 |
Gene therapy for lipid disorders
MK Ma, DJ Rader |
Current controlled trials in cardiovascular medicine | 2000 |
Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
M Mackness, A Bouiller, N Hennuyer, B Mackness, M Hall, A Tailleux, P Duriez, B Delfly, P Durrington, JC Fruchart, N Duverger, JM Caillaud, G Castro |
Biochemical and Biophysical Research Communications | 2000 |
Prevention
JS Forrester |
Current Opinion in Cardiology | 2000 |
Formation of HDL-like complexes from apolipoprotein A-IM and DMPC
M Suurkuusk, SK Singh |
International Journal of Pharmaceutics | 2000 |
MANAGEMENT OF SELECTED LIPID ABNORMALITIES
DJ Rader, S Rosas |
Medical Clinics of North America | 2000 |
Role of plaque rupture in acute coronary syndromes
JS Forrester |
The American Journal of Cardiology | 2000 |
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport
KJ Williams, R Scalia, KD Mazany, WV Rodrigueza, AM Lefer |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Influence of Conjugated Linoleic Acid (CLA) on Establishment and Progression of Atherosclerosis in Rabbits
D Kritchevsky, SA Tepper, S Wright, P Tso, SK Czarnecki |
Journal of the American College of Nutrition | 2000 |
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
M Navab, SY Hama, CJ Cooke, GM Anantharamaiah, M Chaddha, L Jin, G Subbanagounder, KF Faull, ST Reddy, NE Miller, AM Fogelman |
Journal of lipid research | 2000 |
Apolipoprotein A-I, Phospholipid Vesicles, and Cyclodextrins as Potential Anti-Atherosclerotic Drugs: Delivery, Pharmacokinetics, and Efficacy
CR Jessup |
Drug Delivery | 2000 |
Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review
C R Dass, W Jessup |
The Journal of pharmacy and pharmacology | 2000 |
Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice
C Desurmont, JM Caillaud, F Emmanuel, P Benoit, JC Fruchart, G Castro, D Branellec, JM Heard, N Duverger |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally
BS Dhaliwal, UP Steinbrecher |
Journal of lipid research | 2000 |
Risk Reduction
V Fuster, AM Gotto |
Circulation | 2000 |
Gene therapy for dyslipidemia: Clinical prospects
DJ Rader, UJ Tietge |
Current Atherosclerosis Reports | 1999 |
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, J Delattre |
Clinical Chemistry and Laboratory Medicine | 1999 |
A HMG-CoA Reductase Inhibitor Improved Regression of Atherosclerosis in the Rabbit Aorta without Affecting Serum Lipid Levels: Possible Relevance of Up-Regulation of Endothelial NO Synthase mRNA
H Kano, T Hayashi, D Sumi, T Esaki, Y Asai, NK Thakur, M Jayachandran, A Iguchi |
Biochemical and Biophysical Research Communications | 1999 |
Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis
GA Francis, RJ Perry |
Clinica Chimica Acta | 1999 |
Low-density lipoprotein-independent effects of statins
EM Rubin, BY Ishida, SM Clift, RM Krauss |
Current Opinion in Lipidology | 1999 |
Apolipoprotein A-I of Hyperlipidemia Atherosclerosis Prone (LAP) Quail: cDNA Sequence and Tissue Expression
H IWASAKI, H OKU, T TODA, T NASU, K ODA, T MIYAGI, I CHINEN |
Bioscience, Biotechnology, and Biochemistry | 1999 |
Lack of regression of atherosclerotic lesions in phytosterol-treated apo E-deficient mice
MH Moghadasian, DV Godin, BM McManus, JJ Frohlich |
Life Sciences | 1999 |
Pathophysiology and management of low high-density lipoprotein cholesterol
DJ Rader |
The American Journal of Cardiology | 1999 |
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans
M Eriksson, LA Carlson, TA Miettinen, B Angelin |
Circulation | 1999 |
Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
RK Tangirala, K Tsukamoto, SH Chun, D Usher, E Puré, DJ Rader |
Circulation | 1999 |
Inhibition of arterial thrombus formation by ApoA1 Milano
D Li, S Weng, B Yang, DS Zander, T Saldeen, WW Nichols, S Khan, JL Mehta |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
B Föger, M Chase, MJ Amar, BL Vaisman, RD Shamburek, B Paigen, J Fruchart-Najib, JA Paiz, CA Koch, RF Hoyt, HB Brewer, S Santamarina-Fojo |
The Journal of biological chemistry | 1999 |
Lipoprotein A-I Structure
V Koppaka, PH Axelsen |
Trends in Cardiovascular Medicine | 1999 |
Hamsters and Guinea Pigs Differ in Their Plasma Lipoprotein Cholesterol Distribution when Fed Diets Varying in Animal Protein, Soluble Fiber, or Cholesterol Content
ML Fernandez, TA Wilson, K Conde, M Vergara-Jimenez, RJ Nicolosi |
The Journal of nutrition | 1999 |
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
P Benoit, F Emmanuel, JM Caillaud, L Bassinet, G Castro, P Gallix, JC Fruchart, D Branellec, P Denèfle, N Duverger |
Circulation | 1999 |
Reverse Cholesterol Transport and Atherosclerosis Regression
DK Spady |
Circulation | 1999 |
High-Density Lipoproteins Differentially Modulate Cytokine-Induced Expression of E-Selectin and Cyclooxygenase-2
GW Cockerill, J Saklatvala, SH Ridley, H Yarwood, NE Miller, B Oral, S Nithyanathan, G Taylor, DO Haskard |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Expression of Human Scavenger Receptor Class B Type I in Cultured Human Monocyte-Derived Macrophages and Atherosclerotic Lesions
K Hirano, S Yamashita, Y Nakagawa, T Ohya, F Matsuura, K Tsukamoto, Y Okamoto, A Matsuyama, K Matsumoto, J Miyagawa, Y Matsuzawa |
Circulation research | 1999 |
Contemporary Concepts in Cardiology
R Gorlin, G Dangas, PK Toutouzas, MM Konstadoulakis |
1999 | |
Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1
G Lambert, MB Chase, K Dugi, A Bensadoun, HB Brewer, S Santamarina-Fojo |
Journal of lipid research | 1999 |
LIPOPROTEINS AND ATHEROGENESIS
JM Hoeg |
Endocrinology & Metabolism Clinics of North America | 1998 |
Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles
WV Rodrigueza, SK Klimuk, PH Pritchard, MJ Hope |
Biochimica et Biophysica Acta (BBA) - Biomembranes | 1998 |
Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells
A Cucina, S Pagliei, V Borrelli, V Corvino, F Stipa, A Cavallaro, AV Sterpetti |
European Journal of Vascular and Endovascular Surgery | 1998 |
Antiatherosclerotic potency of high density lipoprotein of different origins: a review and some new findings
A Beitz, J Beitz |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1998 |
A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging
T Hara, M Kusunoki, K Tsutsumi, K Okada, S Sakamoto, M Ohnaka, T Nakamura, T Miyata, K Nakayama, A Fukatsu, K Kato, S Kakumu, Y Nakaya |
European Journal of Pharmacology | 1998 |
Evaluation of Lipoproteins/Apolipoproteins as Therapeutic Agents for the Treatment of Vascular and Nonvascular Disease
CR Sirtori |
The American Journal of Cardiology | 1998 |
Atherothrombosis: mechanisms and clinical therapeutic approaches
V Fuster, JJ Badimon, JH Chesebro |
Vascular medicine (London, England) | 1998 |
Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice
PK Shah, J Nilsson, S Kaul, MC Fishbein, H Ageland, A Hamsten, J Johansson, F Karpe, B Cercek |
Circulation | 1998 |
Estradiol Stimulates Apolipoprotein A-I– but Not A-II–Containing Particle Synthesis and Secretion by Stimulating mRNA Transcription Rate in Hep G2 Cells
FY Jin, VS Kamanna, ML Kashyap |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta
Y Ishikawa, Y Akasaka, T Ishii, K Komiyama, S Masuda, N Asuwa, NH Choi-Miura, M Tomita |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
The cardiac toxicity of anabolic steroids
ML Sullivan, CM Martinez, P Gennis, EJ Gallagher |
Progress in Cardiovascular Diseases | 1998 |
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
E Voyiaziakis, IJ Goldberg, AS Plump, EM Rubin, JL Breslow, LS Huang |
Journal of lipid research | 1998 |
Lysosomal sequestration of free and esterified cholesterol from oxidized low density lipoprotein in macrophages of different species
PG Yancey, WG Jerome |
Journal of lipid research | 1998 |
INHIBITION OF ENDOTHELIAL CELL ADHESION MOLECULE EXPRESSION BY HIGH DENSITY LIPOPROTEINS
PJ Barter |
Clinical and Experimental Pharmacology and Physiology | 1997 |
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase
AM Bérard, B Föger, A Remaley, R Shamburek, BL Vaisman, G Talley, B Paigen, RF Hoyt, S Marcovina, HB Brewer, S Santamarina-Fojo |
Nature Medicine | 1997 |
Gene therapy for atherosclerosis
DJ Rader |
International Journal of Clinical & Laboratory Research | 1997 |
Gene Activation, Apolipoprotein A-I/High Density Lipoprotein, Atherosclerosis Prevention and Longevity
PV Luoma |
Pharmacology & Toxicology | 1997 |
Human Lesion Studies
V Fuster |
Annals of the New York Academy of Sciences | 1997 |
Inhibition of VCAM-1 Expression in Endothelial Cells by Reconstituted High Density Lipoproteins
L Calabresi, G Franceschini, CR Sirtori, AD Palma, M Saresella, P Ferrante, D Taramelli |
Biochemical and Biophysical Research Communications | 1997 |
Nikolaj Nikolajewitsch Anitschkow (1885–1964) established the cholesterol-fed rabbit as a model for atherosclerosis research
G Finking, H Hanke |
Atherosclerosis | 1997 |
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery
M Syvänne, MR Taskinen, MS Nieminen, V Manninen, YA Kesäniemi, A Pasternack, JW Nawrocki, H Haber, MH Frick |
Controlled Clinical Trials | 1997 |
Smoking and lipoprotein abnormalities on platelet aggregation in coronary heart disease
AP Mansur, B Caramelli, CB Vianna, D Chamone, JA Ramires |
International Journal of Cardiology | 1997 |
HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
M Viñals, J Martínez-González, JJ Badimon, L Badimon |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells: Implication for Reverse Cholesterol Transport
FY Jin, VS Kamanna, ML Kashyap |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Molecular Basis of Fish-Eye Disease in a Patient From Spain: Characterization of a Novel Mutation in the LCAT Gene and Lipid Analysis of the Cornea
F Blanco-Vaca, SJ Qu, C Fiol, HZ Fan, Q Pao, A Marzal-Casacuberta, JJ Albers, I Hurtado, V Gracia, X Pintó, T Martí, HJ Pownall |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Lysophosphatidylcholine Promotes Cholesterol Efflux From Mouse Macrophage Foam Cells
S Hara, T Shike, N Takasu, T Mizui |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Textbook of Coronary Thrombosis and Thrombolysis
RC Becker |
1997 | |
Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin
LK Hennessy, ST Kunitake, M Jarvis, RL Hamilton, G Endeman, A Protter, JP Kane |
Journal of lipid research | 1997 |
Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion
AJ Mendez |
Journal of lipid research | 1997 |
Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus
K Tsukamoto, KG Hiester, P Smith, DC Usher, JM Glick, DJ Rader |
Journal of lipid research | 1997 |
Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors
Karas |
Journal of Thrombosis and Thrombolysis | 1997 |
Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid
L Lindstedt, M Lee, GR Castro, JC Fruchart, PT Kovanen |
Journal of Clinical Investigation | 1996 |
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
S Zhong, DS Sharp, JS Grove, C Bruce, K Yano, JD Curb, AR Tall |
Journal of Clinical Investigation | 1996 |
High density lipoproteins and coronary heart disease
PJ Barter, KA Rye |
Atherosclerosis | 1996 |
Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns
BE Cham, KM Kostner, AK Dwivedy, TM Shafey, NX Fang, MG Mahon, CI Iannuzzi, DM Colguhoun, JL Smith |
Journal of Clinical Apheresis | 1996 |
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein
M Syvänne, G Castro, C Dengremont, CD Geitere, M Jauhiainen, C Ehnholm, S Michelagnoli, G Franceschini, J Kahri, MR Taskinen |
Atherosclerosis | 1996 |
Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis
JM Hoeg, S Santamarina-Fojo, AM Bérard, JF Cornhill, EE Herderick, SH Feldman, CC Haudenschild, BL Vaisman, RF Hoyt, SJ Demosky, RD Kauffman, CM Hazel, SM Marcovina, HB Brewer |
Proceedings of the National Academy of Sciences | 1996 |
PATHOPHYSIOLOGY OF PLAQUE RUPTURE AND THE CONCEPT OF PLAQUE STABILIZATION
PK Shah |
Cardiology Clinics | 1996 |
Molecular Disorders of Cholesteryl Ester Transfer Protein
S Yamashita, T Arai, K Hirano, N Sakai, M Ishigami, N Nakajima, Y Matsuzawa |
Journal of Atherosclerosis and Thrombosis | 1996 |
Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans
MN Nanjee, JR Crouse, JM King, R Hovorka, SE Rees, ER Carson, JJ Morgenthaler, P Lerch, NE Miller |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver
N Duverger, C Viglietta, L Berthou, F Emmanuel, A Tailleux, L Parmentier-Nihoul, B Laine, C Fievet, G Castro, JC Fruchart, LM Houbebine, P Denèfle |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis
AV Bruschke, JH Reiber, KI Lie, HJ Wellens |
1996 | |
Unstable angina: New insights into pathophysiologic characteristics, prognosis, and management strategies
PA Ribeiro, PM Shah |
Current Problems in Cardiology | 1996 |
Molecular Reviews in Cardiovascular Medicine
K Lindpaintner, D Ganten |
1996 | |
Triggering of Acute Coronary Syndromes
SN Willich, JE Muller |
1996 | |
High-density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm
K Miwa, M Fujita, Y Miyagi, H Inoue, S Sasayama |
Clinical Cardiology | 1995 |
Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits
H Mezdour, T Yamamura, S Nomura, A Yamamoto |
Atherosclerosis | 1995 |
New targets for lipid lowering and atherosclerosis prevention
CR Sirtori |
Pharmacology & Therapeutics | 1995 |
In vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein A1 or apolipoprotein A1 and phosphatidylcholine
J Westman, C Roobol, LA Carlson, E Wülfert |
Scandinavian Journal of Clinical & Laboratory Investigation | 1995 |
Gene therapy for the vulnerable plaque
LJ Feldman, JM Isner |
Journal of the American College of Cardiology | 1995 |
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
GN Levine, JF Keaney, JA Vita |
New England Journal of Medicine | 1995 |
Atherogenic dyslipidemia: Lipoprotein abnormalities and implications for therapy
SM Grundy |
The American Journal of Cardiology | 1995 |
Elucidation off the role of plaque instability and rupture in acute coronary events
V Fuster |
The American Journal of Cardiology | 1995 |
Signal sorting by G-protein-linked receptors
G Milligan |
Advances in pharmacology (San Diego, Calif.) | 1995 |
Multi-functional Aspects of High Density Lipoprotein as an Anti-atherogenic Lipoprotein in vivo : Evidence from in vitro Experiments Using Macrophages
A Miyazaki, M Sakai, H Hakamata, S Horiuchi |
Journal of Atherosclerosis and Thrombosis | 1995 |
The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study*
JA Leuven, MJ van der Mooren, R Buytenhek |
Fertility and Sterility | 1995 |
Antioxidants and Cardiovascular Disease
KR Bruckdorfer |
1995 | |
Arterial Thrombosis for the Clinician
RC Becker |
Cardiology Clinics | 1995 |
Effects of 1 Year of Growth Hormone Therapy on Serum Lipoprotein Levels in Growth Hormone–Deficient Adults: Influence of Gender and Apo(a) and ApoE Phenotypes
G Johannsson, J Oscarsson, T Rosén, O Wiklund, G Olsson, L Wilhelmsen, BA Bengtsson |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Apolipoprotein A-I Deficiency: Biochemical and Metabolic Characteristics
DS Ng, C Vezina, TS Wolever, A Kuksis, RA Hegele, PW Connelly |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti |
1995 | |
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
GW Cockerill, KA Rye, JR Gamble, MA Vadas, PJ Barter |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Apolipoprotein B and E Basic Amino Acid Clusters Influence Low-Density Lipoprotein Association with Lipoprotein Lipase Anchored to the Subendothelial Matrix
U Saxena, BJ Auerbach, E Ferguson, J Wölle, YL Marcel, KH Weisgraber, RA Hegele, CL Bisgaier |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
K Hirano, S Yamashita, Y Kuga, N Sakai, S Nozaki, S Kihara, T Arai, K Yanagi, S Takami, M Menju, M Ishigami, Y Yoshida, K Kameda-Takemura, K Hayashi, Y Matsuzawa |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Coronary Plaque Disruption
E Falk, PK Shah, V Fuster |
Circulation | 1995 |
Transcription factors as drug targets: opportunities for therapeutic selectivity
T R Butt, S K Karathanasis |
Gene expression | 1995 |
Sex steroids and lipoprotein metabolism
JA Leuven |
Pharmacology & Therapeutics | 1994 |
Regression of Atherosclerosis
W Krupski |
Annals of Vascular Surgery | 1994 |
Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferation
T Vogel, NH Guo, R Guy, N Drezlich, HC Krutzsch, DA Blake, A Panet, DD Roberts |
Journal of Cellular Biochemistry | 1994 |
Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta
M Ferrer, A Encabo, J Marín, G Balfagón |
European Journal of Pharmacology | 1994 |
Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
AS Plump, CJ Scott, JL Breslow |
Proceedings of the National Academy of Sciences | 1994 |
Is the antiatherosclerotic potency of HDL modulated by the origin of HDL?
A Beitz, J Beitz, HJ Mest |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1994 |
Effects of Simvastatin and Pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits
PA Jorge, MR Ozaki, K Metze |
Experimental and Toxicologic Pathology | 1994 |
Drug control of reverse cholesterol transport
G Franceschini, JP werba, L Calabresi |
Pharmacology & Therapeutics | 1994 |
Dyslipidemias and the secondary prevention of coronary heart disease
RS Rosenson, WA Frauenheim, CC Tangney |
Disease-a-Month | 1994 |
The metabolism of high-density lipoproteins
AG Lacko |
Trends in Cardiovascular Medicine | 1994 |
In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
MN Pieters, D Schouten, TJ Berkel |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 1994 |
Structural relation between HDL-binding proteins in porcine liver
RP de Crom, R van Haperen, P Visser, R Willemsen, AW van der Kamp |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits
S Ameli, A Hultgardh-Nilsson, B Cercek, PK Shah, JS Forrester, H Ageland, J Nilsson |
Circulation | 1994 |
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology
V Fuster |
Circulation | 1994 |
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis
H Drexel, FW Amann, J Beran, K Rentsch, R Candinas, J Muntwyler, A Luethy, T Gasser, F Follath |
Circulation | 1994 |
Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol
WP Kopfler, M Willard, T Betz, JE Willard, RD Gerard, RS Meidell |
Circulation | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity
RM Epand, A Stafford, B Leon, PE Lock, EM Tytler, JP Segrest, GM Anantharamaiah |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice
AC Liu, RM Lawn, JG Verstuyft, EM Rubin |
Journal of lipid research | 1994 |
The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis
K Tsutsumi, Y Inoue, A Shima, K Iwasaki, M Kawamura, T Murase |
Journal of Clinical Investigation | 1993 |
High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene
KJ Lackner, H Dieplinger, G Nowicka, G Schmitz |
Journal of Clinical Investigation | 1993 |
Animal models of human lipid metabolism
KE Suckling, B Jackson |
Progress in Lipid Research | 1993 |
Reverse cholesterol transport: relationship between free cholesterol uptake and HDL3 in normolipidaemic and hyperlipidaemic subjects
MC Cabezas, GP van Heusden, TW de Bruin, JR van Beckhoven, LA Kock, KW Wtrtz, DW Erkelens |
European Journal of Clinical Investigation | 1993 |
Toward the quiescent coronary plaque
AI MacIsaac, JA Thomas, EJ Topol |
Journal of the American College of Cardiology | 1993 |
Adenine for guanine substitution - pairs 5‘ to the apolipoprotein (APO) A4 gene: relation with hgh density lipoprotein cholesterol and APO A-I concentrations
F Civeira, M Pocovi, A Cenarro, C Garces, JM Ordovas |
Clinical Genetics | 1993 |
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia
DJ Rader, JR Schaefer, P Lohse, K Ikewaki, F Thomas, WA Harris, LA Zech, CA Dujovne, HB Brewer |
Metabolism | 1993 |
High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells
Y Ko, R Häring, H Stiebler, AJ Wieczorek, H Vetter, A Sachinidis |
Atherosclerosis | 1993 |
Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
HB Rubins, SJ Robins, MK Iwane, WE Boden, MB Elam, CL Fye, DJ Gordon, EJ Schaefer, G Schectman, JT Wittes |
The American Journal of Cardiology | 1993 |
The role of subfractions of high density lipoprotein in the in vivo transport of cholesterol from cholesterol-loaded hepatic and peripheral endothelial cells in the new zealand white rabbit
YD Fragoso, ER Skinner |
Comparative Biochemistry and Physiology Part B: Comparative Biochemistry | 1993 |
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice
C Glass, RC Pittman, DB Weinstein, D Steinberg |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins
D Crook, IF Godsland, M Worthington, CV Felton, AJ Proudler, JC Stevenson |
American Journal of Obstetrics and Gynecology | 1993 |
Growth Factors and the Cardiovascular System
P Cummins |
1993 | |
Human Apolipoprotein Mutants III
CR Sirtori, G Franceschini, BH Brewer |
1993 | |
Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix
U Saxena, E Ferguson, CL Bisgaier |
The Journal of biological chemistry | 1993 |
Concentration and distribution of apolipoproteins A-I and E in normolipidemic, WHHL and diet-induced hyperlipidemic rabbit sera
H Mezdour, S Nomura, T Yamamura, A Yamamoto |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1992 |
Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: Implications for a mechanism for atherosclerosis protection
RN Amarasuriya, AK Gupta, M Civen, YC Horng, T Maeda, ML Kashyap |
Metabolism | 1992 |
Does a HDL injection reduce the development of serum hyperlipidemia and progression of fatty streaks in cholesterol fed rabbits?
J Beitz, A Beitz, IV Antonov, AY Misharin, HJ Mest |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1992 |
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
FH Epstein, V Fuster, L Badimon, JJ Badimon, JH Chesebro |
New England Journal of Medicine | 1992 |
High density lipoprotein mediates selective reduction in cholesteryl esters from macrophage foam cells
A Miyazaki, AT Rahim, T Ohta, Y Morino, S Horiuchi |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1992 |
Norgestimate: A clinical overview of a new progestin
J Bringer |
American Journal of Obstetrics and Gynecology | 1992 |
Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol
M Miller, A Seidler, PO Kwiterovich, TA Pearson |
Circulation | 1992 |
Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty
PK Shah, J Amin |
Circulation | 1992 |
High density lipoprotein deficiency syndrome in chickens is not associated with an increased susceptibility to atherosclerosis
F Poernama, R Subramanian, ME Cook, AD Attie |
Arteriosclerosis Thrombosis and Vascular Biology | 1992 |
Reverse cholesterol transport: Physiology and pharmacology
G Franceschini, P Maderna, CR Sirtori |
Atherosclerosis | 1991 |
More on Chewing the Fat
FM Sacks, WW Willett |
New England Journal of Medicine | 1991 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |
Cholesterol transport between cells and high-density lipoproteins
WJ Johnson, FH Mahlberg, GH Rothblat, MC Phillips |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1991 |
Resolved and unresolved issues in the prevention and treatment of coronary artery disease: A workshop consensus statement
V Dzau, E Braunwald |
American Heart Journal | 1991 |
Accelerated coronary atherosclerosis in cardiac transplantation
DO Taylor, HM Ibrahim, DR Tolman, ML Hess |
Transplantation Reviews | 1991 |
Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice
T Hayek, T Chajek-Shaul, A Walsh, N Azrolan, JL Breslow |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
JH Ip, V Fuster, L Badimon, J Badimon, MB Taubman, JH Chesebro |
Journal of the American College of Cardiology | 1990 |
Animal models of atherosclerosis
ML Armstrong, DD Heistad |
Atherosclerosis | 1990 |
The Biology of the Laboratory Rabbit
HA Hartman |
The Biology of the Laboratory Rabbit | 1974 |